Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,5.743945674964322e-47,28.75323795180723,3061.4536542414617,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS23']",2.998339642331376e-44,0,0,66
2,Nuclear Receptors Meta-Pathway WP2882,6.528418056466417e-08,2.6659674270897065,44.107140987112246,"['SRXN1', 'AMIGO2', 'MGST1', 'IRS2', 'DBI', 'SLC2A4', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'AKAP13', 'DNAJB1', 'RGS2', 'FTH1', 'DNER', 'ENC1', 'CCL2', 'STOM', 'HES1', 'JUNB', 'SLC19A2', 'CBR3', 'EGR1', 'SREBF1', 'NQO1', 'HSP90AA1', 'GPX2', 'GADD45B', 'GPX3', 'PTGES3', 'HGF', 'SLC39A11', 'NRG1', 'SMARCA1', 'SLC39A14', 'SOD3', 'NFKB2', 'SLC2A9', 'TGFBR3', 'SCD', 'FASN', 'BHLHE40', 'PMP2', 'ANGPTL4', 'GCLM', 'EPHA2', 'HSPA1A', 'FKBP5', 'FTL']",1.703917112737735e-05,0,0,48
3,Differentiation Pathway WP2848,2.2803949882257684e-05,7.606410930110352,81.3017073726655,"['NT5E', 'KITLG', 'NOTCH1', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'WNT5A', 'FGF2', 'VEGFA']",0.0035741209392546824,0,0,10
4,Glucocorticoid Receptor Pathway WP2880,3.045213006674046e-05,4.066675462901878,42.29080023602113,"['HSP90AA1', 'GADD45B', 'PTGES3', 'AMIGO2', 'NFKB2', 'TGFBR3', 'AKAP13', 'RGS2', 'DNER', 'ENC1', 'BHLHE40', 'CCL2', 'STOM', 'PMP2', 'ANGPTL4', 'SLC19A2']",0.0035741209392546824,0,0,16
5,Hematopoietic Stem Cell Differentiation WP2849,3.51094415459377e-05,6.1381537719932515,62.959291673442145,"['HES6', 'CIITA', 'MUC1', 'KITLG', 'NOTCH1', 'CSF1', 'TRIM29', 'PIM1', 'CXCR4', 'NFATC2', 'RUNX1']",0.0035741209392546824,0,0,11
6,Vitamin D Receptor Pathway WP2877,4.10818498764906e-05,3.1504916241806264,31.819789426723766,"['CDKN1A', 'SERPINB1', 'STEAP4', 'IGFBP5', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'SLC2A4', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'ID1', 'DNER', 'S100A6', 'TIMP2', 'CD9', 'PRKCQ', 'JUNB', 'ZNF257']",0.0035741209392546824,0,0,21
7,Peptide GPCRs WP24,6.25849136075954e-05,7.525559566787003,72.8397879888059,"['OXTR', 'EDNRA', 'CCKBR', 'GNRHR', 'CXCR4', 'TAC4', 'TACR1', 'CCR10', 'NTSR2']",0.0046670464147378285,0,0,9
8,"GPCRs, Class A Rhodopsin-like WP455",7.387137746344322e-05,3.3563953488372094,31.930010287610276,"['GPR27', 'P2RY12', 'GPR39', 'OXTR', 'NPFFR1', 'HTR1E', 'P2RY14', 'GPR87', 'CXCR4', 'EDNRA', 'CCKBR', 'GPR171', 'APLNR', 'ACKR4', 'CCR10', 'DRD4', 'NTSR2', 'GPR19']",0.00482010737948967,0,0,18
9,Complement and Coagulation Cascades WP558,0.0003716374520716517,5.37354306343476,42.438049474163286,"['C1QB', 'CPB2', 'C1S', 'C1R', 'PROS1', 'CFI', 'SERPING1', 'F3', 'KLKB1']",0.020744075489501124,0,0,9
10,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.00039739608217435104,1.933661818971131,15.141687932753507,"['PFKFB1', 'LAMA5', 'CDKN1A', 'CRTC2', 'CSF1', 'LAMA2', 'CAB39L', 'IRS1', 'COL11A2', 'LAMA3', 'TNC', 'PIK3CD', 'IRS2', 'HIF3A', 'SLC2A4', 'PIK3C2A', 'FGF2', 'IGF1R', 'GHR', 'GNG3', 'CREB3L4', 'TNR', 'IFNAR2', 'SREBF1', 'HSP90AA1', 'ITGA3', 'EGF', 'HGF', 'RPS6', 'FN1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A2', 'COL5A1', 'COL4A1', 'FGFR3', 'EPHA2']",0.020744075489501124,0,0,39
11,NRF2 pathway WP2884,0.0006107675421545488,2.48166346952802,18.36628042780021,"['EGR1', 'NQO1', 'HSP90AA1', 'GPX2', 'SRXN1', 'GPX3', 'HGF', 'SLC39A11', 'NRG1', 'SLC2A4', 'SLC5A3', 'SLC39A14', 'SOD3', 'SLC2A9', 'DNAJB1', 'FTH1', 'GCLM', 'FTL', 'EPHA2', 'CBR3', 'HSPA1A']",0.028983696091334044,0,0,21
12,Spinal Cord Injury WP2431,0.0007829654623525425,2.6470318237454102,18.93268857761354,"['C1QB', 'EGR1', 'BTG2', 'ANXA1', 'IL1R1', 'GADD45A', 'BDNF', 'PLA2G5', 'TACR1', 'ICAM1', 'GFAP', 'LGALS3', 'NR4A1', 'ZFP36', 'GAP43', 'COL4A1', 'CCL2', 'SLIT3']",0.0340589976123356,0,0,18
13,IL-18 signaling pathway WP4754,0.0008900043585191772,1.9329391891891892,13.57751420238908,"['BTG2', 'CEBPB', 'NRN1', 'CD81', 'TSHZ1', 'RGS16', 'PLOD3', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'SOCS3', 'TMSB4X', 'NFKBIZ', 'CCL2', 'RPS11', 'TICAM2', 'FN1', 'IL18', 'TACR1', 'KLF2', 'VEGFA', 'NFKB2', 'TNFRSF1A', 'ACTA2', 'CCNA2', 'NR4A1', 'CLDN4', 'KITLG', 'FAS', 'CYCS', 'KIFC3', 'PTPN7', 'MYD88', 'ARF6']",0.03573709808823158,0,0,34
14,Folate Metabolism WP176,0.0010502526722171264,3.9808698045692266,27.30368927406167,"['SERPINA3', 'GPX2', 'CSF1', 'GPX3', 'CCL2', 'SOD2', 'LDLR', 'SOD3', 'ICAM1', 'NFKB2']",0.03915942106409571,0,0,10
15,Globo Sphingolipid Metabolism WP1424,0.001190405776111443,5.84477289113194,39.35555055974686,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'ST6GALNAC3', 'A4GALT', 'ST6GALNAC5']",0.041426121008678214,0,0,7
16,IL1 and megakaryocytes in obesity WP2865,0.0013332521996106638,7.15356113627007,47.357533719026826,"['IL1R1', 'IL18', 'TIMP2', 'CCL2', 'MYD88', 'ICAM1']",0.04264295705932459,0,0,6
17,Type II interferon signaling (IFNG) WP619,0.001388755306529728,4.7730364873222015,31.403465183562357,"['SOCS3', 'CIITA', 'HLA-B', 'TAP1', 'GBP1', 'IRF9', 'ICAM1', 'PSMB9']",0.04264295705932459,0,0,8
18,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.001542952986066838,3.021461903612519,19.561117116790303,"['SREBF1', 'CDKN1A', 'CEBPB', 'NOTCH1', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'EMD', 'HES5']",0.044745636595938304,0,0,13
19,Adipogenesis WP236,0.001777370362909452,2.296664074495025,14.543901612096834,"['WWTR1', 'SREBF1', 'CDKN1A', 'CEBPB', 'GADD45B', 'CEBPD', 'IRS1', 'GADD45A', 'EBF1', 'IRS2', 'SLC2A4', 'SOCS3', 'KLF6', 'BMP1', 'SCD', 'NAMPT', 'PNPLA3', 'ID3', 'FAS', 'RXRG']",0.048830912075722835,0,0,20
20,Complement system WP2806,0.0020495618821036355,3.284603863237269,20.332122365451117,"['LAMA5', 'RPS19', 'C1S', 'C1R', 'PROS1', 'CFI', 'F11', 'SERPING1', 'CD59', 'KLKB1', 'ICAM1']",0.05324970798032846,0,0,11
21,Genotoxicity pathway WP4286,0.002206781633334553,3.041178792264176,18.600518854993627,"['ACTA2', 'ITPKC', 'PLK3', 'BTG2', 'CDKN1A', 'RPS27', 'DAAM1', 'CEBPD', 'SERTAD1', 'GADD45A', 'ID2', 'TRIM22']",0.05324970798032846,0,0,12
22,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0022442405662207398,8.341252699784016,50.87653739667783,"['CDKN1A', 'GALNT3', 'FAM20C', 'FGFR3', 'NFKB2']",0.05324970798032846,0,0,5
23,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.002856292710577675,2.0960276967930027,12.279013906326945,"['EGR1', 'SNAP25', 'CEBPB', 'VIPR2', 'CAV3', 'CHRNA4', 'BDNF', 'CHRNA7', 'TACR1', 'GCK', 'NFKB2', 'VEGFA', 'ADCYAP1', 'PRKAR2B', 'SST', 'PAH', 'BHLHE40', 'HES1', 'TAC1', 'YWHAG', 'HES5', 'YWHAH']",0.0648254258661542,0,0,22
24,Gene regulatory network modelling somitogenesis  WP2854,0.0035437544917697092,11.11558752997602,62.72046431096305,"['LFNG', 'NOTCH1', 'HES1', 'TBX6']",0.07255332763252298,0,0,4
25,Striated Muscle Contraction Pathway WP383,0.003555220046765373,4.49481448616272,25.347779572291504,"['ACTA2', 'ACTN2', 'TPM2', 'TCAP', 'NEB', 'ACTG1', 'TTN']",0.07255332763252298,0,0,7
26,ID signaling pathway WP53,0.003752758325820154,6.950443964482841,38.82006554196371,"['SREBF1', 'ID2', 'ID1', 'ID3', 'ELK3']",0.07255332763252298,0,0,5
27,miR-509-3p alteration of YAP1/ECM axis WP3967,0.003752758325820154,6.950443964482841,38.82006554196371,"['EDNRA', 'COL5A1', 'PBX3', 'FN1', 'TEAD3']",0.07255332763252298,0,0,5
28,Vitamin A and carotenoid metabolism WP716,0.004594745189924331,3.7110790444123776,19.976152065730233,"['RBP4', 'RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG', 'RLBP1', 'RPE65']",0.08565917818358931,0,0,8
29,VEGFA-VEGFR2 Signaling Pathway WP3888,0.004973435787273891,1.5031275884721944,7.972054175642627,"['PLOD3', 'HSPB1', 'NRARP', 'PTPRJ', 'RPL10A', 'RPL7', 'ICAM1', 'ACTG1', 'RND1', 'TUBA1C', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'RPLP2', 'RPS11', 'TMSB10', 'ADAMTS9', 'MAP2K3', 'HSP90AA1', 'ANXA1', 'RPS6', 'GAB1', 'F3', 'TXNIP', 'MYH9', 'RPL27', 'RPL26', 'DSC1', 'ARF6', 'EPHA2', 'SHC1', 'PLA2G5', 'NDRG1', 'APOLD1', 'HDAC7', 'LDHA', 'DNAJB4', 'CCL2', 'MAP2K6', 'EGR1', 'EGR3', 'FN1', 'NFATC2', 'NFATC1', 'BMX', 'SOD2', 'RAB11A', 'VEGFA', 'DNAJA1', 'NR4A1', 'NR4A3', 'P4HA2', 'PTPN9', 'FAS', 'CYCS', 'HSPA1A']",0.08952184417093004,0,0,56
30,Overview of nanoparticle effects WP3287,0.005869501101811002,5.95700915355343,30.607027487875268,"['CCND3', 'COL4A1', 'LAMA3', 'FN1', 'PIK3CD']",0.10212931917151144,0,0,5
31,Vitamin B12 metabolism WP1533,0.006458691376114132,3.8948329728430666,19.639027516176565,"['SERPINA3', 'CCL2', 'SOD2', 'LDLR', 'SOD3', 'ICAM1', 'NFKB2']",0.10868744226415791,0,0,7
32,p53 transcriptional gene network WP4963,0.0066628317096801785,2.5719692752977847,12.88867996057164,"['BTG2', 'CDKN1A', 'NOTCH1', 'TRAF4', 'GLS2', 'GADD45A', 'SESN1', 'CCL2', 'FAS', 'IRF9', 'PML', 'ICAM1']",0.10868744226415791,0,0,12
33,Neural Crest Differentiation WP2064,0.007024439832445553,2.3416521739130434,11.610754018986164,"['SMAD1', 'NOTCH1', 'COL11A2', 'TBX6', 'FGF2', 'GFAP', 'NFKB2', 'HDAC7', 'DCT', 'ID1', 'ZIC1', 'HES1', 'FGFR3', 'HES5']",0.11111386644050239,0,0,14
34,Hypertrophy Model WP516,0.00870466499385979,5.211933045356371,24.724869320768732,"['NR4A3', 'IL1R1', 'IFRD1', 'IL18', 'VEGFA']",0.13364220961161208,0,0,5
35,Selenium Micronutrient Network WP15,0.009584613233058287,2.5529243994536834,11.864961877102893,"['SERPINA3', 'GPX2', 'SELENOM', 'GPX3', 'CCL2', 'SOD2', 'LDLR', 'SOD3', 'ICAM1', 'SELENOH', 'NFKB2']",0.14294766021875502,0,0,11
36,Liver X receptor pathway WP2874,0.010449031099898457,12.497124370956147,57.002458830748004,"['SREBF1', 'SCD', 'FASN']",0.14688881631481665,0,0,3
37,miR-517 relationship with ARCN1 and USP1 WP3596,0.010449031099898457,12.497124370956147,57.002458830748004,"['CDKN1A', 'ID2', 'ID1']",0.14688881631481665,0,0,3
38,Transcriptional cascade regulating adipogenesis WP4211,0.010693055593798914,6.668201438848921,30.261370097141665,"['SREBF1', 'CEBPB', 'CEBPD', 'KLF2']",0.14688881631481665,0,0,4
39,Osteoblast differentiation WP4787,0.011341739521218778,2.0589036507759295,9.222376287398307,"['HES6', 'SMAD1', 'NOTCH1', 'FZD5', 'FZD4', 'WNT7B', 'WNT5A', 'FZD9', 'SMAD9', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'FGF2', 'GLI2', 'PRKCQ', 'FGFR3']",0.1518048212840052,0,0,16
40,Differentiation of white and brown adipocyte WP2895,0.0123614016853565,4.632429405647549,20.35107967120275,"['SMAD1', 'CEBPB', 'ZIC1', 'SMAD9', 'SLC7A10']",0.16131629199390232,0,0,5
41,DNA damage response WP707,0.013148509045042101,2.4181413403356546,10.474050830232635,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'GADD45A', 'SESN1', 'CHEK2', 'TNFRSF10B', 'FAS', 'CYCS', 'PML']",0.1674029688173653,0,0,11
42,Signal transduction through IL1R WP4496,0.013681936110677004,3.244853000080109,13.925866986103896,"['MAP2K3', 'IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.16976370770258495,0,0,7
43,Mitochondrial CIV Assembly WP4922,0.014309584557306012,2.9030679465462073,12.328823614955267,"['COX8A', 'COX19', 'COA3', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX14', 'COX5B']",0.16976370770258495,0,0,8
44,The influence of laminopathies on Wnt signaling WP4844,0.014309584557306012,2.9030679465462073,12.328823614955267,"['SREBF1', 'CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'SLC2A4', 'EMD', 'HES5']",0.16976370770258495,0,0,8
45,Development and heterogeneity of the ILC family WP3893,0.01632561349510928,5.556354916067146,22.864511742440705,"['NFIL3', 'ZBTB16', 'ID2', 'IL18']",0.18937711654326764,0,0,4
46,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.01696751707760789,2.590763102203411,10.561127965733121,"['MAP2K3', 'CCNA2', 'CDKN1A', 'HSP90AA1', 'FAS', 'JUNB', 'TNFRSF1A', 'MCL1', 'MAP2K6']",0.1925444329241591,0,0,9
47,miRNA regulation of DNA damage response WP1530,0.017634920652237047,2.296836587129429,9.274337230669138,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'GADD45A', 'SESN1', 'CHEK2', 'TNFRSF10B', 'FAS', 'CYCS', 'PML']",0.1958601825631434,0,0,11
48,Blood Clotting Cascade WP272,0.01923825943282219,8.330697340043134,32.91337144045111,"['F11', 'F3', 'KLKB1']",0.2003528621182953,0,0,3
49,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.01923825943282219,8.330697340043134,32.91337144045111,"['LFNG', 'NOTCH1', 'TBX6']",0.2003528621182953,0,0,3
50,PI3K-Akt signaling pathway WP4172,0.01945821724471308,1.5371173156992408,6.055451865322029,"['LAMA5', 'CDKN1A', 'CSF1', 'LAMA2', 'IRS1', 'LAMA3', 'TNC', 'PIK3CD', 'FGF2', 'IGF1R', 'GHR', 'CCND3', 'GNG3', 'CCND2', 'CREB3L4', 'TNR', 'MCL1', 'IFNAR2', 'HSP90AA1', 'BDNF', 'ITGA3', 'EGF', 'HGF', 'RPS6', 'FN1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A2', 'COL4A1', 'FGFR3', 'EPHA2']",0.2003528621182953,0,0,33
51,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.019574704919603565,2.0172663668165915,7.934951772464971,"['SHC1', 'EGF', 'HGF', 'RPS6', 'GAB1', 'PIK3CD', 'NRG1', 'FGF2', 'IGF1R', 'VEGFA', 'MRAS', 'PLCG2', 'GAS6', 'FGFR3']",0.2003528621182953,0,0,14
52,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.02058347021432926,1.785805924412666,6.934761111234109,"['MAP2K3', 'NOTCH1', 'FZD5', 'SHC1', 'FZD4', 'WNT7B', 'WNT5A', 'FZD9', 'FN1', 'PIK3CD', 'WNT7A', 'CLDN4', 'CLDN20', 'COL4A2', 'COL4A1', 'MMP15', 'ID2', 'ID1', 'MAP2K6']",0.204715729353892,0,0,19
53,Allograft Rejection WP2328,0.020785313516774477,2.6703607503607505,10.343665391952825,"['C1QB', 'COL5A1', 'HLA-B', 'HLA-DPB1', 'HLA-C', 'FAS', 'HLA-E', 'VEGFA']",0.204715729353892,0,0,8
54,Interferon type I signaling pathways WP585,0.021908958478676584,2.3191634553628773,8.861198098151505,"['IFNAR2', 'MAP2K3', 'SOCS3', 'IRS1', 'RPS6', 'PDCD4', 'PIK3CD', 'IRS2', 'IRF9', 'MAP2K6']",0.2080047668965994,0,0,10
55,Endochondral Ossification with Skeletal Dysplasias WP4808,0.02344484919704027,2.4231978572260395,9.094514682176671,"['GHR', 'ADAMTS1', 'COL10A1', 'FGF2', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.2080047668965994,0,0,9
56,Endochondral Ossification WP474,0.02344484919704027,2.4231978572260395,9.094514682176671,"['GHR', 'ADAMTS1', 'COL10A1', 'FGF2', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.2080047668965994,0,0,9
57,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.02351011733122484,4.762178828365879,17.859715579801662,"['NOTCH1', 'TNC', 'CXCR4', 'VEGFA']",0.2080047668965994,0,0,4
58,FOXA2 pathway WP5066,0.02351011733122484,4.762178828365879,17.859715579801662,"['SREBF1', 'IRS1', 'FASN', 'IRS2']",0.2080047668965994,0,0,4
59,Glutathione metabolism WP100,0.02351011733122484,4.762178828365879,17.859715579801662,"['GPX2', 'GPX3', 'OPLAH', 'GCLM']",0.2080047668965994,0,0,4
60,Heart Development WP1591,0.02495785434975634,3.12725144092219,11.54133003892377,"['SMAD1', 'NOTCH1', 'BHLHE40', 'NFATC2', 'NFATC1', 'VEGFA']",0.21357377000939032,0,0,6
61,Oxidative Stress WP408,0.02495785434975634,3.12725144092219,11.54133003892377,"['NQO1', 'GPX3', 'MGST1', 'SOD2', 'JUNB', 'SOD3']",0.21357377000939032,0,0,6
62,Alpha 6 Beta 4 signaling pathway WP244,0.025378361172307247,2.7805815909637106,10.215463008153343,"['LAMA5', 'LAMA2', 'SHC1', 'IRS1', 'LAMA3', 'GAB1', 'IRS2']",0.21366942793458685,0,0,7
63,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.02727026095957691,2.347269855595668,8.454768637956727,"['SREBF1', 'SQLE', 'SCD', 'FASN', 'MSMO1', 'DHCR24', 'DHCR7', 'HSD17B7', 'TM7SF2']",0.225953590807923,0,0,9
64,Ebola Virus Pathway on Host WP4217,0.028400602018619787,1.7763888888888888,6.326333574168028,"['CAV3', 'ITGA3', 'ACTN1', 'HLA-B', 'HLA-C', 'PIK3CD', 'IGF1R', 'ACTG1', 'HLA-E', 'NFKB2', 'BST2', 'SOCS3', 'NEDD4', 'IRF7', 'HLA-DPB1', 'FLNA', 'GAS6']",0.2263147489954836,0,0,17
65,Ferroptosis WP4313,0.029102231172866654,2.4721286943509164,8.743771939911658,"['STEAP3', 'MAP1LC3A', 'FTH1', 'ACSL6', 'GCLM', 'CP', 'SLC39A14', 'FTL']",0.2263147489954836,0,0,8
66,Transcription factor regulation in adipogenesis WP3599,0.029124960308318872,3.4734221262299014,12.282575447723728,"['CEBPB', 'CEBPD', 'IRS1', 'IRS2', 'SLC2A4']",0.2263147489954836,0,0,5
67,Oncostatin M Signaling Pathway WP2374,0.029877345745128087,2.0873101952277655,7.327825458169625,"['SOCS3', 'EGR1', 'CEBPB', 'IRS1', 'SHC1', 'RPS6', 'CCL2', 'OSMR', 'JUNB', 'LDLR', 'VEGFA']",0.2263147489954836,0,0,11
68,"GPCRs, Other WP117",0.03044940701663009,2.6539621157501476,9.26680968642481,"['EDNRA', 'CCKBR', 'GRM8', 'GNRHR', 'LGR6', 'DRD4', 'GPR135']",0.2263147489954836,0,0,7
69,Prostaglandin Synthesis and Regulation WP98,0.030787882277274668,2.943041193422614,10.24364953251047,"['HSD11B1', 'EDNRA', 'ANXA1', 'ANXA2', 'S100A6', 'S100A10']",0.2263147489954836,0,0,6
70,Insulin signaling in adipocytes (diabetic condition) WP3635,0.031009164546417868,6.247483824586628,21.700463181786763,"['IRS1', 'RPS6', 'SLC2A4']",0.2263147489954836,0,0,3
71,Insulin signaling in adipocytes (normal condition) WP3634,0.031009164546417868,6.247483824586628,21.700463181786763,"['IRS1', 'RPS6', 'SLC2A4']",0.2263147489954836,0,0,3
72,Benzene metabolism WP3891,0.032082933765643265,16.652298850574713,57.2744336975288,"['NQO1', 'EPHX1']",0.2263147489954836,0,0,2
73,EV release from cardiac cells and their functional effects WP3297,0.032082933765643265,16.652298850574713,57.2744336975288,"['RGS16', 'KLF2']",0.2263147489954836,0,0,2
74,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.032082933765643265,16.652298850574713,57.2744336975288,"['NRP1', 'VEGFA']",0.2263147489954836,0,0,2
75,Small cell lung cancer WP4658,0.033345229538828076,1.8563607085346217,6.3131867900267356,"['LAMA5', 'CDKN1A', 'LAMA2', 'GADD45B', 'ITGA3', 'GADD45A', 'LAMA3', 'FN1', 'PIK3CD', 'TRAF4', 'COL4A2', 'COL4A1', 'CYCS', 'RXRG']",0.23208279759024342,0,0,14
76,Focal Adhesion WP306,0.03589098821832683,1.5770886393801342,5.247398202449723,"['VASP', 'LAMA5', 'CAV3', 'LAMA2', 'SHC1', 'ITGA3', 'EGF', 'ACTN1', 'HGF', 'LAMA3', 'FN1', 'TNC', 'PIK3CD', 'MYL12A', 'VEGFA', 'ACTG1', 'IGF1R', 'CCND3', 'CCND2', 'COL4A2', 'COL4A1', 'FLNA', 'TNR']",0.24357560448571158,0,0,23
77,ESC Pluripotency Pathways WP3931,0.03592973476130228,1.7902724541593287,5.954786441680106,"['MAP2K3', 'SMAD1', 'FZD5', 'FZD4', 'EGF', 'WNT7B', 'WNT5A', 'FZD9', 'GAB1', 'SMAD9', 'PIK3CD', 'WNT7A', 'FGF2', 'FGFR3', 'MAP2K6']",0.24357560448571158,0,0,15
78,Nonalcoholic fatty liver disease WP4396,0.036659763012484206,1.6111641954602858,5.326630474800673,"['COX8A', 'SREBF1', 'XBP1', 'NDUFA7', 'IRS1', 'NDUFA4', 'COX4I1', 'NDUFB2', 'PIK3CD', 'IRS2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'TNFRSF1A', 'SOCS3', 'UQCRQ', 'CYCS', 'CCL2', 'FAS']",0.24429377370314992,0,0,21
79,Aryl Hydrocarbon Receptor Pathway WP2873,0.03743965880508045,2.7792987512007685,9.130065159008758,"['NQO1', 'HSP90AA1', 'PTGES3', 'MGST1', 'HES1', 'JUNB']",0.24429377370314992,0,0,6
80,Lung fibrosis WP3624,0.03743965880508045,2.7792987512007685,9.130065159008758,"['CEBPB', 'EGF', 'HGF', 'CCL2', 'ATP11A', 'FGF2']",0.24429377370314992,0,0,6
81,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.04253154272287512,2.432378034126412,7.680256255642852,"['MAP1LC3A', 'IGFBP5', 'IRS1', 'NEB', 'FBXO32', 'IGF1R', 'TNFRSF1A']",0.2740921642140841,0,0,7
82,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.04572217485355864,4.997555715312725,15.418318322692249,"['SMAD1', 'SST', 'SMAD9']",0.28092409164319576,0,0,3
83,Complement Activation WP545,0.04572217485355864,4.997555715312725,15.418318322692249,"['C1QB', 'C1S', 'C1R']",0.28092409164319576,0,0,3
84,Inflammatory Response Pathway WP453,0.04572217485355864,4.997555715312725,15.418318322692249,"['LAMA5', 'FN1', 'TNFRSF1A']",0.28092409164319576,0,0,3
85,Cardiac Progenitor Differentiation WP2406,0.045744344424658315,2.9767047207651958,9.182202694432245,"['NOTCH1', 'BMP1', 'CXCR4', 'NRG1', 'FGF2']",0.28092409164319576,0,0,5
86,IL-1 signaling pathway WP195,0.04742742875912962,1.9868221855216075,6.056935817366963,"['MAP2K3', 'IL1R1', 'IRAK2', 'HSPB2', 'CCL2', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.28787346293332167,0,0,10
87,IL-4 signaling pathway WP395,0.05302714391577243,2.0291930920089767,5.9596413852631756,"['SOCS3', 'CEBPB', 'NFIL3', 'IRS1', 'SHC1', 'INPP5D', 'PIK3CD', 'FLNA', 'IRS2']",0.3181628634946346,0,0,9
88,Cori Cycle WP1946,0.05501857479470449,3.332661870503597,9.665000791855164,"['LDHA', 'GPT', 'SLC2A4', 'PFKP']",0.32547450515308735,0,0,4
89,Metapathway biotransformation Phase I and II WP702,0.055492779614223706,1.670195794053662,4.829375086404943,"['HS3ST3B1', 'CHST9', 'GPX2', 'CHST6', 'HS3ST3A1', 'CHST7', 'GPX3', 'CYP4F3', 'EPHX1', 'MGST1', 'KCNAB1', 'CYP3A5', 'NAA80', 'CYP3A7', 'CYP39A1']",0.32547450515308735,0,0,15
90,Breast cancer pathway WP4262,0.05637088910986978,1.5829865361077111,4.5523564864559205,"['CDKN1A', 'NOTCH1', 'GADD45B', 'FZD5', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'WNT5A', 'FZD9', 'PIK3CD', 'WNT7A', 'FGF2', 'IGF1R', 'NFKB2', 'FRAT2', 'HES1', 'HES5']",0.32695115683724474,0,0,18
91,Cardiac Hypertrophic Response WP2795,0.059608345836399367,1.97562226866806,5.571175148263254,"['MAP2K3', 'EGF', 'NFATC2', 'NRG1', 'FGF2', 'MAP3K14', 'TNFRSF1A', 'HDAC7', 'MAP2K6']",0.334660290087305,0,0,9
92,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.059608345836399367,1.97562226866806,5.571175148263254,"['MAP2K3', 'IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.334660290087305,0,0,9
93,GABA metabolism (aka GHB) WP4157,0.05962338501555434,8.325431034482758,23.475279627941106,"['PON3', 'ADHFE1']",0.334660290087305,0,0,2
94,Wnt signaling in kidney disease WP4150,0.06257278651047388,2.3816385343762865,6.60053213613663,"['FZD5', 'FZD4', 'WNT7B', 'WNT5A', 'FZD9', 'WNT7A']",0.34747866551561024,0,0,6
95,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.0658048215242285,2.1615530454751797,5.88172021593247,"['IFITM3', 'MAP2K3', 'BST2', 'IFITM2', 'RPS6KA2', 'JUNB', 'MAP2K6']",0.36158017721733976,0,0,7
96,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.06690773546318002,2.0216012943285673,5.467300801926398,"['EIF4A2', 'MAP2K3', 'RPS6KA2', 'RPS6', 'PIM1', 'PDCD4', 'PIM2', 'MAP2K6']",0.36381081158104134,0,0,8
97,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.06886802529427645,3.0294310006540224,8.105434353070306,"['ICAM1', 'NFKB2', 'VEGFA', 'TNFRSF1A']",0.3668276449348195,0,0,4
98,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.06886802529427645,3.0294310006540224,8.105434353070306,"['SREBF1', 'SCD', 'FASN', 'LDLR']",0.3668276449348195,0,0,4
99,DNA damage response (only ATM dependent) WP710,0.07367678227159802,1.6230475040257648,4.233017543029288,"['CDKN1A', 'IRS1', 'SHC1', 'WNT7B', 'WNT5A', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'SOD2', 'NFKB2', 'CCND3', 'CCND2', 'BCL6', 'LDLR']",0.38355714683737385,0,0,14
100,Wnt signaling WP428,0.07367678227159802,1.6230475040257648,4.233017543029288,"['FZD5', 'WNT7B', 'WNT5A', 'FZD9', 'PRICKLE2', 'NFATC2', 'WNT7A', 'NFATC1', 'CCND3', 'CCND2', 'FRAT2', 'DAAM1', 'DAAM2', 'WIF1']",0.38355714683737385,0,0,14
101,Myometrial relaxation and contraction pathways WP289,0.07421316442638842,1.5184989429175475,3.9493328942640655,"['RGS17', 'OXTR', 'IGFBP5', 'RGS16', 'ADCY2', 'ACTG1', 'RGS4', 'ACTA2', 'RGS2', 'GNG3', 'GRK5', 'PRKAR2B', 'PLCG2', 'PRKCQ', 'CALM3', 'IGFBP6', 'YWHAG', 'YWHAH']",0.38355714683737385,0,0,18
102,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.07936735037459196,2.4507686443908017,6.20943457898488,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.40617408721114706,0,0,5
103,Neovascularisation processes WP4331,0.0837429929296699,2.174163638641774,5.391931864285659,"['SMAD1', 'KITLG', 'NOTCH1', 'CXCR4', 'SMAD9', 'NFKB2']",0.4232442765456622,0,0,6
104,miRNA targets in ECM and membrane receptors WP2911,0.0843245301930055,2.77673860911271,6.867103576398308,"['COL4A2', 'COL5A1', 'COL4A1', 'FN1']",0.4232442765456622,0,0,4
105,miRNAs involvement in the immune response in sepsis WP4329,0.09286165566188681,2.314414846812255,5.500541239771305,"['IRF7', 'TAB2', 'MYD88', 'ICAM1', 'NFKB2']",0.4572998514670275,0,0,5
106,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.09286165566188681,2.314414846812255,5.500541239771305,"['BMP1', 'P4HA2', 'P3H2', 'TNFRSF11B', 'COLGALT1']",0.4572998514670275,0,0,5
107,Apoptosis Modulation and Signaling WP1772,0.09985514582623684,1.638325069724202,3.774757785757114,"['IL1R1', 'BAG3', 'TNFRSF10B', 'FAS', 'CYCS', 'TNFRSF11B', 'MAP3K14', 'MYD88', 'TNFRSF1A', 'MCL1', 'HSPA1A']",0.467577589223231,0,0,11
108,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.10010350251999507,1.7451431449920243,4.01653525778829,"['LAMA2', 'ACTN2', 'ITGA3', 'ACTN1', 'CACNA2D3', 'CACNG2', 'EMD', 'DSC2', 'ACTG1']",0.467577589223231,0,0,9
109,Angiogenesis WP1539,0.10130902443387141,2.5629219701162147,5.868014334534406,"['SMAD1', 'TIMP2', 'FGF2', 'VEGFA']",0.467577589223231,0,0,4
110,Apoptosis Modulation by HSP70 WP384,0.10130902443387141,2.5629219701162147,5.868014334534406,"['FAS', 'CYCS', 'TNFRSF1A', 'HSPA1A']",0.467577589223231,0,0,4
111,Microglia Pathogen Phagocytosis Pathway WP3937,0.10130902443387141,2.5629219701162147,5.868014334534406,"['C1QB', 'PLCG2', 'PIK3CD', 'PIK3C2A']",0.467577589223231,0,0,4
112,"GPCRs, Class B Secretin-like WP334",0.10577835833529195,3.1226635514018692,7.014780545932147,"['VIPR2', 'CALCRL', 'ADGRG2']",0.467577589223231,0,0,3
113,Kynurenine Pathway and links to Cellular Senescence WP5044,0.10577835833529195,3.1226635514018692,7.014780545932147,"['CDKN1A', 'AADAT', 'HAAO']",0.467577589223231,0,0,3
114,Leptin Insulin Overlap WP3935,0.10577835833529195,3.1226635514018692,7.014780545932147,"['SOCS3', 'IRS1', 'IRS2']",0.467577589223231,0,0,3
115,Nicotine Activity on Dopaminergic Neurons WP1602,0.10577835833529195,3.1226635514018692,7.014780545932147,"['CHRNA4', 'ADCY2', 'DRD4']",0.467577589223231,0,0,3
116,NOTCH1 regulation of endothelial cell calcification WP3413,0.10577835833529195,3.1226635514018692,7.014780545932147,"['NOTCH1', 'FGFR3', 'VEGFA']",0.467577589223231,0,0,3
117,Tryptophan catabolism leading to NAD+ production WP4210,0.10577835833529195,3.1226635514018692,7.014780545932147,"['AADAT', 'HAAO', 'NAMPT']",0.467577589223231,0,0,3
118,Tryptophan metabolism WP465,0.10744639949710653,2.192414080557766,4.890756573534302,"['WARS', 'MAOB', 'AADAT', 'HAAO', 'DHCR24']",0.467577589223231,0,0,5
119,White fat cell differentiation WP4149,0.10744639949710653,2.192414080557766,4.890756573534302,"['SREBF1', 'CEBPB', 'CEBPD', 'EBF1', 'KLF2']",0.467577589223231,0,0,5
120,Calcium Regulation in the Cardiac Cell WP536,0.10752719087002603,1.4478458049886622,3.2287128316520106,"['RGS17', 'RGS16', 'ATP1A4', 'ADCY2', 'ATP1B2', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'GRK5', 'PRKAR2B', 'CAMK4', 'GJA9', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.467577589223231,0,0,17
121,Oxidative Damage WP3941,0.10838484347894818,1.9998847262247839,4.44387789406035,"['C1QB', 'CDKN1A', 'C1S', 'C1R', 'GADD45A', 'CYCS']",0.467577589223231,0,0,6
122,Wnt signaling pathway and pluripotency WP399,0.11896224763660962,1.5397083379717245,3.2779606541433526,"['CCND3', 'CCND2', 'FZD5', 'FZD4', 'WNT7B', 'WNT5A', 'ESRRB', 'FZD9', 'WNT7A', 'PRKCQ', 'LDLR', 'CD44']",0.5004597960260789,0,0,12
123,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.11972243151801926,2.379650565262076,5.050996998132858,"['NQO1', 'SRXN1', 'EPHX1', 'GCLM']",0.5004597960260789,0,0,4
124,Urea cycle and associated pathways WP4595,0.11972243151801926,2.379650565262076,5.050996998132858,"['OAT', 'GLS2', 'PYCR1', 'GPT']",0.5004597960260789,0,0,4
125,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.11984190517865875,1.667292418772563,3.5372973537408567,"['CDKN1A', 'DAAM1', 'FZD5', 'SHC1', 'FZD4', 'TMSB4X', 'FZD9', 'FN1', 'PFN2']",0.5004597960260789,0,0,9
126,Glioblastoma signaling pathways WP2261,0.1260588328515071,1.5546159785286224,3.2196198798864706,"['MAP2K3', 'CDKN1A', 'CCND2', 'IRS1', 'GAB1', 'PLCG2', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'IGF1R', 'MAP2K6']",0.5151230905326131,0,0,11
127,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.12899039116319877,4.161997126436781,8.523842385948928,"['SOCS3', 'CHI3L1']",0.5151230905326131,0,0,2
128,"Phase I biotransformations, non P450 WP136",0.12899039116319877,4.161997126436781,8.523842385948928,"['PON3', 'PON1']",0.5151230905326131,0,0,2
129,PTF1A related regulatory pathway WP4147,0.12899039116319877,4.161997126436781,8.523842385948928,"['NOTCH1', 'HES1']",0.5151230905326131,0,0,2
130,Cancer immunotherapy by PD-1 blockade WP4585,0.13026101139905158,2.775461298825785,5.656987021683474,"['NFATC2', 'NFATC1', 'PDCD1LG2']",0.5151230905326131,0,0,3
131,Fatty acid transporters WP5061,0.13026101139905158,2.775461298825785,5.656987021683474,"['FABP5', 'ACSL6', 'DBI']",0.5151230905326131,0,0,3
132,Galanin receptor pathway WP4970,0.13026101139905158,2.775461298825785,5.656987021683474,"['CDKN1A', 'SLC2A4', 'VEGFA']",0.5151230905326131,0,0,3
133,Aryl Hydrocarbon Receptor Netpath WP2586,0.13631152798630186,1.851424911943644,3.689542458908881,"['NQO1', 'CDKN1A', 'HSP90AA1', 'KLF6', 'PSRC1', 'VEGFA']",0.5274845164764029,0,0,6
134,Phosphoinositides metabolism WP4971,0.13631152798630186,1.851424911943644,3.689542458908881,"['INPP5D', 'PLCG2', 'PIK3CD', 'PIP4K2A', 'PLCE1', 'PIK3C2A']",0.5274845164764029,0,0,6
135,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.1375245421786959,1.6668109668109667,3.306874433405479,"['SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'NRG1', 'YBX3', 'CARD14']",0.5274845164764029,0,0,8
136,miRNA regulation of p53 pathway in prostate cancer WP3982,0.13944992964318698,2.2208153477218224,4.37511654166558,"['CHEK2', 'SHISA5', 'TNFRSF10B', 'CYS1']",0.5274845164764029,0,0,4
137,Ovarian infertility WP34,0.13944992964318698,2.2208153477218224,4.37511654166558,"['EGR1', 'CEBPB', 'CCND2', 'SYNE2']",0.5274845164764029,0,0,4
138,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.13944992964318698,2.2208153477218224,4.37511654166558,"['IFNAR2', 'IRF7', 'IRF9', 'MYD88']",0.5274845164764029,0,0,4
139,MAPK Signaling Pathway WP382,0.14411600207851152,1.2845254161043635,2.4883013689248004,"['PTPRR', 'HSPB1', 'FGF2', 'FLNA', 'MAP3K6', 'CACNG2', 'MAP2K6', 'MAP2K3', 'IL1R1', 'GADD45A', 'BDNF', 'EGF', 'CACNA2D3', 'NFATC1', 'HSPA2', 'NFKB2', 'TNFRSF1A', 'NR4A1', 'MRAS', 'FAS', 'TAB2', 'PTPN7', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.5392490298855958,0,0,26
140,One-carbon metabolism and related pathways WP3940,0.14462617659766935,1.7154883582849145,3.317073363985012,"['GPX2', 'AHCYL1', 'GPX3', 'CHDH', 'SOD2', 'GCLM', 'SOD3']",0.5392490298855958,0,0,7
141,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.15184941824325973,1.3758472610835963,2.5932876116505894,"['MAP2K3', 'SREBF1', 'IRS1', 'SHC1', 'PIK3CD', 'IRS2', 'SLC2A4', 'PIK3C2A', 'SLCO1C1', 'SCD', 'RPS6KA2', 'FASN', 'TRIP10', 'MAP3K6', 'MAP3K14', 'MAP2K6']",0.5621659313686637,0,0,16
142,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.15307064789897176,1.5626805054151625,2.9329258344794047,"['CCND3', 'FRAT2', 'CCND2', 'FZD5', 'WIF1', 'WNT7B', 'WNT5A', 'FZD9', 'WNT7A']",0.5626963253750934,0,0,9
143,Retinoblastoma gene in cancer WP2446,0.15487439157304872,1.5155018392012611,2.8266244151321627,"['CCNA2', 'BARD1', 'CDKN1A', 'CCND3', 'H2AFZ', 'PRIM1', 'RPA3', 'RBP1', 'HMGB2', 'CDC7']",0.5627658608958754,0,0,10
144,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1564900853930364,2.4976994967649175,4.632639670410011,"['EGF', 'CD81', 'HSPB1']",0.5627658608958754,0,0,3
145,IL17 signaling pathway WP2112,0.15720587123930044,1.8929576542967472,3.50234845524874,"['CEBPB', 'CEBPD', 'IL17RE', 'MAP3K14', 'IL17RB']",0.5627658608958754,0,0,5
146,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.16036494571541127,2.0818345323741005,3.8103883031223176,"['LAMA5', 'CCND2', 'WNT5A', 'GLI2']",0.5627658608958754,0,0,4
147,Immune response to tuberculosis WP4197,0.16036494571541127,2.0818345323741005,3.8103883031223176,"['IFNAR2', 'TAP1', 'IFI35', 'IRF9']",0.5627658608958754,0,0,4
148,Pyrimidine metabolism WP4022,0.16627673575987514,1.4554052037783056,2.6111450896789727,"['NT5C', 'POLE4', 'POLD4', 'PRIM1', 'NME2', 'NME3', 'ENPP3', 'POLR2I', 'POLR2K', 'NME1', 'POLR2L']",0.5627658608958754,0,0,11
149,Biogenic Amine Synthesis WP550,0.16818290095738805,3.329310344827586,5.935172190881099,"['PNMT', 'PAH']",0.5627658608958754,0,0,2
150,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.16818290095738805,3.329310344827586,5.935172190881099,"['DHCR24', 'DHCR7']",0.5627658608958754,0,0,2
151,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.16818290095738805,3.329310344827586,5.935172190881099,"['CSF1', 'ID2']",0.5627658608958754,0,0,2
152,Dual hijack model of Vif in HIV infection WP3300,0.16818290095738805,3.329310344827586,5.935172190881099,"['ELOB', 'RUNX1']",0.5627658608958754,0,0,2
153,Estrogen metabolism WP697,0.16818290095738805,3.329310344827586,5.935172190881099,"['NQO1', 'ARSE']",0.5627658608958754,0,0,2
154,Farnesoid X receptor pathway WP2879,0.16818290095738805,3.329310344827586,5.935172190881099,"['IRS2', 'FKBP5']",0.5627658608958754,0,0,2
155,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.16818290095738805,3.329310344827586,5.935172190881099,"['HES1', 'VEGFA']",0.5627658608958754,0,0,2
156,Platelet-mediated interactions with vascular and circulating cells WP4462,0.16818290095738805,3.329310344827586,5.935172190881099,"['CCL2', 'ICAM1']",0.5627658608958754,0,0,2
157,Exercise-induced Circadian Regulation WP410,0.17296037364787256,1.619903068172715,2.8424321933672387,"['DNAJA1', 'CEBPB', 'RBPMS', 'PPP1R3C', 'TAB2', 'ERC2', 'ETV6']",0.5750657009184044,0,0,7
158,Senescence and Autophagy in Cancer WP615,0.17721601961892022,1.4325402205350688,2.4788473138863734,"['MAP2K3', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'IGFBP5', 'IFI16', 'FN1', 'IRF7', 'COL10A1', 'CD44', 'IGF1R']",0.5826589791482806,0,0,11
159,MECP2 and Associated Rett Syndrome WP3584,0.17747658560263718,1.499913357400722,2.5932250884711094,"['CEBPD', 'BCL6', 'BDNF', 'SST', 'RPS6', 'TAP1', 'FGF2', 'IGF1R', 'FKBP5']",0.5826589791482806,0,0,9
160,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.18233280892763307,1.9592044011849343,3.3344123701359463,"['TICAM2', 'IRAK2', 'CCL2', 'MYD88']",0.5893617069136176,0,0,4
161,Imatinib and Chronic Myeloid Leukemia WP3640,0.18416414149997848,2.2704398405332986,3.8414203881047495,"['GADD45A', 'PIM1', 'PIM2']",0.5893617069136176,0,0,3
162,Phytochemical activity on NRF2 transcriptional activation WP3,0.18416414149997848,2.2704398405332986,3.8414203881047495,"['NQO1', 'CEBPB', 'GCLM']",0.5893617069136176,0,0,3
163,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.18416414149997848,2.2704398405332986,3.8414203881047495,"['ID1', 'TNC', 'FN1']",0.5893617069136176,0,0,3
164,Insulin Signaling WP481,0.1851634481491059,1.288348854397635,2.172821395147611,"['MAP2K3', 'EGR1', 'SNAP25', 'XBP1', 'IRS1', 'SHC1', 'GAB1', 'PIK3CD', 'IRS2', 'SLC2A4', 'PIK3C2A', 'IGF1R', 'SOCS3', 'RPS6KA2', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'MAP2K6', 'ARF6']",0.5893617069136176,0,0,19
165,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.18987683896841784,1.5147579693034239,2.5165880390647746,"['IFI27L2', 'PLCG2', 'PLCE1', 'CCL2', 'PRKCQ', 'RXRG', 'TNFRSF1A', 'NFKB2']",0.6007012723728128,0,0,8
166,TNF-alpha signaling pathway WP231,0.20007340571319324,1.3888888888888888,2.2348207655647805,"['MAP2K3', 'HSP90AA1', 'OTUD7B', 'CCL2', 'TAB2', 'PYGL', 'RFFL', 'MAP3K14', 'TNFRSF1A', 'MAP2K6', 'NFKB2']",0.606109146957774,0,0,11
167,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.20207336386398086,1.4122660918977172,2.2583892516840414,"['MAP2K3', 'EGF', 'WNT5A', 'PIK3CD', 'NRG1', 'FGF2', 'MAP3K14', 'IGF1R', 'HDAC7', 'MAP2K6']",0.606109146957774,0,0,10
168,Aflatoxin B1 metabolism WP699,0.20319128295400127,8.320172290021537,13.259088655210268,['EPHX1'],0.606109146957774,0,0,1
169,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.20319128295400127,8.320172290021537,13.259088655210268,['FAS'],0.606109146957774,0,0,1
170,SCFA and skeletal muscle substrate metabolism WP4030,0.20319128295400127,8.320172290021537,13.259088655210268,['SLC2A4'],0.606109146957774,0,0,1
171,Head and Neck Squamous Cell Carcinoma WP4674,0.203515336540182,1.4419744515412385,2.295643389196152,"['CDKN1A', 'NOTCH1', 'SESN1', 'RPS6', 'GAB1', 'FGFR3', 'IGF1R', 'NFKB2', 'VEGFA']",0.606109146957774,0,0,9
172,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.20412618091566267,1.4809684143017476,2.353283901560065,"['LAMA5', 'CDKN1A', 'NOTCH1', 'CD151', 'ITGA3', 'PODXL', 'PLCE1', 'MYH9']",0.606109146957774,0,0,8
173,TLR4 Signaling and Tolerance WP3851,0.20521402541050338,1.8501998401278976,2.9301648505988496,"['INPP5D', 'IRF7', 'TAB2', 'MYD88']",0.606109146957774,0,0,4
174,Toll-like Receptor Signaling related to MyD88 WP3858,0.20521402541050338,1.8501998401278976,2.9301648505988496,"['TICAM2', 'IRF7', 'MYD88', 'NFKB2']",0.606109146957774,0,0,4
175,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.20890488769966628,1.3513904642703485,2.1161101829835958,"['COX8A', 'NDUFA7', 'UQCRQ', 'NDUFA4', 'COX4I1', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'SLC25A5', 'COX5B', 'COX7A1']",0.606109146957774,0,0,12
176,Biomarkers for urea cycle disorders WP4583,0.20900315412337034,2.7741858237547894,4.342726955051403,"['GLS2', 'GPT']",0.606109146957774,0,0,2
177,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.20900315412337034,2.7741858237547894,4.342726955051403,"['EGF', 'FN1']",0.606109146957774,0,0,2
178,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.20900315412337034,2.7741858237547894,4.342726955051403,"['ANXA2', 'LDLR']",0.606109146957774,0,0,2
179,Nanoparticle triggered regulated necrosis WP2513,0.20900315412337034,2.7741858237547894,4.342726955051403,"['TNFRSF1A', 'FTL']",0.606109146957774,0,0,2
180,RAS and bradykinin pathways in COVID-19 WP4969,0.20900315412337034,2.7741858237547894,4.342726955051403,"['SERPING1', 'KLKB1']",0.606109146957774,0,0,2
181,Cholesterol Biosynthesis Pathway WP197,0.21298817544489934,2.081056793673616,3.2183930997497447,"['SQLE', 'MSMO1', 'DHCR7']",0.6075400414329916,0,0,3
182,Mitochondrial complex III assembly WP4921,0.21298817544489934,2.081056793673616,3.2183930997497447,"['UQCRQ', 'UQCR11', 'UQCR10']",0.6075400414329916,0,0,3
183,NAD+ metabolism WP3644,0.21298817544489934,2.081056793673616,3.2183930997497447,"['NT5E', 'NAMPT', 'CD38']",0.6075400414329916,0,0,3
184,Notch Signaling WP268,0.21841982283863748,1.5614643371757926,2.375512338759359,"['LFNG', 'NUMBL', 'NOTCH1', 'DTX3L', 'HES1', 'HES5']",0.6191805628964633,0,0,6
185,G1 to S cell cycle control WP45,0.2194413872334209,1.4949069195644538,2.267280643144221,"['CDKN1A', 'CCND3', 'CCND2', 'CREB3L4', 'GADD45A', 'PRIM1', 'RPA3']",0.6191805628964633,0,0,7
186,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.2288671578020517,1.7526694433926544,2.5845100935690115,"['RAB3B', 'HSPB1', 'NDRG1', 'RAB11A']",0.6423046041541451,0,0,4
187,CAMKK2  Pathway WP4874,0.2349275270108446,1.601179597939857,2.319273754870594,"['FIS1', 'MAP1LC3A', 'CAMK4', 'NFATC2', 'ICAM1']",0.6522987718067068,0,0,5
188,Type 2 papillary renal cell carcinoma WP4241,0.2349275270108446,1.601179597939857,2.319273754870594,"['CDKN1A', 'EGLN3', 'COL21A1', 'ELOB', 'VEGFA']",0.6522987718067068,0,0,5
189,Pregnane X receptor pathway WP2876,0.24267978807302232,1.920809600176962,2.7198903063663624,"['HSP90AA1', 'CYP3A5', 'CYP3A7']",0.6667307861795666,0,0,3
190,Statin inhibition of cholesterol production WP430,0.24267978807302232,1.920809600176962,2.7198903063663624,"['SQLE', 'APOC1', 'LDLR']",0.6667307861795666,0,0,3
191,Dopamine metabolism WP2436,0.25065070057253264,2.3776683087027917,3.289967608353055,"['NQO1', 'MAOB']",0.6814565921815731,0,0,2
192,Thiamine metabolic pathways WP4297,0.25065070057253264,2.3776683087027917,3.289967608353055,"['SLC19A3', 'SLC19A2']",0.6814565921815731,0,0,2
193,Cell cycle WP179,0.26868710145800995,1.2653098609609994,1.6628800482255157,"['CCNA2', 'CCND3', 'CDKN1A', 'CCND2', 'GADD45B', 'GADD45A', 'CHEK2', 'CDC7', 'YWHAG', 'ANAPC11', 'YWHAH', 'SMC1B']",0.7101093437514174,0,0,12
194,Ectoderm Differentiation WP2858,0.2718334565591219,1.2252058183679564,1.5959110649824617,"['KCNK10', 'FZD5', 'TSC22D1', 'FZD4', 'ZBTB16', 'HMGB2', 'TNFRSF11B', 'NFATC1', 'MAFB', 'PODXL', 'BOC', 'PIM1', 'RHPN1', 'CCL2', 'KIFC3']",0.7101093437514174,0,0,15
195,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.27297352279187337,1.7834548628941151,2.315602971331736,"['TGFBR3', 'SHC1', 'FLNA']",0.7101093437514174,0,0,3
196,Monoamine Transport WP727,0.27297352279187337,1.7834548628941151,2.315602971331736,"['IL1R1', 'TNFRSF11B', 'FBXO32']",0.7101093437514174,0,0,3
197,Urea cycle and metabolism of amino groups WP497,0.27297352279187337,1.7834548628941151,2.315602971331736,"['ARG2', 'OAT', 'PYCR1']",0.7101093437514174,0,0,3
198,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.2745569281643569,1.314915447463424,1.699655303683764,"['CCND3', 'CCND2', 'FRAT2', 'FZD5', 'WIF1', 'WNT7B', 'WNT5A', 'FZD9', 'WNT7A']",0.7101093437514174,0,0,9
199,Regulation of toll-like receptor signaling pathway WP1449,0.27538254987521904,1.2724853378324095,1.6409895299629482,"['MAP2K3', 'IFNAR2', 'TICAM2', 'IRAK2', 'SFTPD', 'IRF7', 'PIK3CD', 'TAB2', 'MYD88', 'MAP2K6', 'NFKB2']",0.7101093437514174,0,0,11
200,Glycolysis and Gluconeogenesis WP534,0.27719456794020936,1.4865525043710788,1.9072997963197478,"['LDHA', 'PGAM2', 'SLC2A4', 'GCK', 'PFKP']",0.7101093437514174,0,0,5
201,Hepatitis C and Hepatocellular Carcinoma WP3646,0.27719456794020936,1.4865525043710788,1.9072997963197478,"['CDKN1A', 'COL4A2', 'PODXL', 'CD44', 'VEGFA']",0.7101093437514174,0,0,5
202,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.28087166114020234,1.3322943722943723,1.691823915463871,"['TUBA1C', 'TUBB6', 'TUBB2B', 'TUBA1A', 'RNF19A', 'HSPA2', 'HSPA1B', 'HSPA1A']",0.7101093437514174,0,0,8
203,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.28087166114020234,1.3322943722943723,1.691823915463871,"['MAP2K3', 'EGR1', 'CCND3', 'RPS6', 'ADCY2', 'RALGDS', 'IGF1R', 'MAP2K6']",0.7101093437514174,0,0,8
204,COVID-19 adverse outcome pathway WP4891,0.2887454628549904,4.159727207465901,5.167253612615506,['CCL2'],0.7101093437514174,0,0,1
205,Drug Induction of Bile Acid Pathway WP2289,0.2887454628549904,4.159727207465901,5.167253612615506,['SLC51A'],0.7101093437514174,0,0,1
206,Hfe effect on hepcidin production WP3924,0.2887454628549904,4.159727207465901,5.167253612615506,['ID1'],0.7101093437514174,0,0,1
207,Hypothetical Craniofacial Development Pathway WP3655,0.2887454628549904,4.159727207465901,5.167253612615506,['ARHGAP29'],0.7101093437514174,0,0,1
208,let-7 inhibition of ES cell reprogramming WP3299,0.2887454628549904,4.159727207465901,5.167253612615506,['EGR1'],0.7101093437514174,0,0,1
209,Macrophage markers WP4146,0.2887454628549904,4.159727207465901,5.167253612615506,['F3'],0.7101093437514174,0,0,1
210,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.2887454628549904,4.159727207465901,5.167253612615506,['CCKBR'],0.7101093437514174,0,0,1
211,Steroid Biosynthesis WP496,0.2887454628549904,4.159727207465901,5.167253612615506,['HSD17B7'],0.7101093437514174,0,0,1
212,Eicosanoid Synthesis WP167,0.2924779864110244,2.080280172413793,2.5574254549780875,"['PNPLA3', 'PLA2G5']",0.7101093437514174,0,0,2
213,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.2924779864110244,2.080280172413793,2.5574254549780875,"['GRM3', 'GRM8']",0.7101093437514174,0,0,2
214,Iron metabolism in placenta WP2007,0.2924779864110244,2.080280172413793,2.5574254549780875,"['STEAP3', 'FTH1']",0.7101093437514174,0,0,2
215,miRNAs involved in DNA damage response WP1545,0.2924779864110244,2.080280172413793,2.5574254549780875,"['CDKN1A', 'CCND3']",0.7101093437514174,0,0,2
216,Toll-like Receptor Signaling Pathway WP75,0.2970904948496339,1.306057776646012,1.5851864726888547,"['MAP2K3', 'IFNAR2', 'TICAM2', 'IRF7', 'PIK3CD', 'TAB2', 'MYD88', 'MAP2K6']",0.7179686958866153,0,0,8
217,IL-2 signaling pathway WP49,0.29887981684249015,1.435167945185075,1.7332720419500522,"['SOCS3', 'CCND2', 'SHC1', 'RPS6', 'NMI']",0.7189643520358519,0,0,5
218,Oxidation by Cytochrome P450 WP43,0.30306404573737605,1.5132766514061478,1.8065664997418758,"['CYP39A1', 'CYP4F3', 'CYP3A5', 'CYP3A7']",0.7204163247604555,0,0,4
219,Ebstein-Barr virus LMP1 signaling WP262,0.3036237384047897,1.6644140905823148,1.9839250837533746,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.7204163247604555,0,0,3
220,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.3036237384047897,1.6644140905823148,1.9839250837533746,"['UGCG', 'GALNT16', 'ST6GALNAC3']",0.7204163247604555,0,0,3
221,Fas ligand pathway and stress induction of heat shock proteins WP314,0.32082058106097616,1.3872090232781378,1.5770808301973265,"['HSPB1', 'FAS', 'CYCS', 'ACTG1', 'LMNB1']",0.7529831000038107,0,0,5
222,Nephrotic syndrome WP4758,0.32082058106097616,1.3872090232781378,1.5770808301973265,"['CD151', 'PODXL', 'ITGA3', 'PLCE1', 'MYH9']",0.7529831000038107,0,0,5
223,Circadian rhythm related genes WP3594,0.3216766883158042,1.160595021250759,1.3163565192844424,"['KLF10', 'EGR1', 'SREBF1', 'EGR3', 'CARTPT', 'PML', 'CIART', 'CLDN4', 'NFIL3', 'ID2', 'NOCT', 'NAMPT', 'BHLHE40', 'ID3', 'FAS', 'RPS27A', 'DRD4']",0.7529831000038107,0,0,17
224,Synaptic Vesicle Pathway WP2267,0.33253674117667453,1.314234794478993,1.4469789816055723,"['SNAP25', 'RIMS1', 'SLC22A3', 'SLC38A1', 'SLC17A6', 'SYN3']",0.7556714306110182,0,0,6
225,GPR40 Pathway WP3958,0.33396678704533744,1.8489782886334611,2.0277998773430532,"['PLCG2', 'PLCE1']",0.7556714306110182,0,0,2
226,Matrix Metalloproteinases WP129,0.33396678704533744,1.8489782886334611,2.0277998773430532,"['MMP15', 'TIMP2']",0.7556714306110182,0,0,2
227,Genes controlling nephrogenesis WP4823,0.33440632274165744,1.5602534148094895,1.7090992349586287,"['ITGA3', 'CXCR4', 'VEGFA']",0.7556714306110182,0,0,3
228,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.33440632274165744,1.5602534148094895,1.7090992349586287,"['LDHA', 'RPS6', 'VEGFA']",0.7556714306110182,0,0,3
229,Vitamin D in inflammatory diseases WP4482,0.33440632274165744,1.5602534148094895,1.7090992349586287,"['MAP2K3', 'NFATC1', 'MAP2K6']",0.7556714306110182,0,0,3
230,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.33440632274165744,1.5602534148094895,1.7090992349586287,"['WIF1', 'ZBTB16', 'PML']",0.7556714306110182,0,0,3
231,Zinc homeostasis WP3529,0.33440632274165744,1.5602534148094895,1.7090992349586287,"['SLC39A11', 'SLC30A10', 'SLC39A14']",0.7556714306110182,0,0,3
232,Prolactin Signaling Pathway WP2037,0.34686913179050427,1.2331783442894555,1.305698741186873,"['SOCS3', 'IRS1', 'SHC1', 'RPS6KA2', 'RPS6', 'FLNA', 'IRS2', 'YWHAG']",0.777928077908329,0,0,8
233,PPAR signaling pathway WP3942,0.352393640154783,1.280425626246952,1.3354921642788882,"['FABP5', 'SCD', 'ACSL6', 'DBI', 'ANGPTL4', 'RXRG']",0.777928077908329,0,0,6
234,Benzo(a)pyrene metabolism WP696,0.3651194748306243,2.772912179947356,2.7937940128764884,['EPHX1'],0.777928077908329,0,0,1
235,Cells and molecules involved in local acute inflammatory response  WP4493,0.3651194748306243,2.772912179947356,2.7937940128764884,['ICAM1'],0.777928077908329,0,0,1
236,Composition of Lipid Particles WP3601,0.3651194748306243,2.772912179947356,2.7937940128764884,['LDLR'],0.777928077908329,0,0,1
237,FTO Obesity Variant Mechanism WP3407,0.3651194748306243,2.772912179947356,2.7937940128764884,['ARID5B'],0.777928077908329,0,0,1
238,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3651194748306243,2.772912179947356,2.7937940128764884,['OPLAH'],0.777928077908329,0,0,1
239,Irinotecan pathway WP229,0.3651194748306243,2.772912179947356,2.7937940128764884,['CYP3A5'],0.777928077908329,0,0,1
240,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.3651194748306243,2.772912179947356,2.7937940128764884,['CDKN1A'],0.777928077908329,0,0,1
241,Small Ligand GPCRs WP247,0.3651194748306243,2.772912179947356,2.7937940128764884,['S1PR3'],0.777928077908329,0,0,1
242,Tamoxifen metabolism WP691,0.3651194748306243,2.772912179947356,2.7937940128764884,['CYP3A5'],0.777928077908329,0,0,1
243,The alternative pathway of fetal androgen synthesis WP4524,0.3651194748306243,2.772912179947356,2.7937940128764884,['HSD17B6'],0.777928077908329,0,0,1
244,Canonical and non-canonical Notch signaling WP3845,0.36511950016770234,1.4683469361864083,1.4794044421114194,"['NOTCH1', 'DNER', 'HES1']",0.777928077908329,0,0,3
245,Fatty Acid Biosynthesis WP357,0.36511950016770234,1.4683469361864083,1.4794044421114194,"['SCD', 'FASN', 'ACSL6']",0.777928077908329,0,0,3
246,BMP Signaling Pathway in Eyelid Development WP3927,0.3747079327991494,1.6639367816091954,1.6333343257879673,"['SMAD1', 'NOTCH1']",0.7823901636846239,0,0,2
247,Computational Model of Aerobic Glycolysis WP4629,0.3747079327991494,1.6639367816091954,1.6333343257879673,"['LDHA', 'PGAM2']",0.7823901636846239,0,0,2
248,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3747079327991494,1.6639367816091954,1.6333343257879673,"['CCL2', 'NFKB2']",0.7823901636846239,0,0,2
249,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3747079327991494,1.6639367816091954,1.6333343257879673,"['MAP3K14', 'MAP2K6']",0.7823901636846239,0,0,2
250,Pyrimidine metabolism and related diseases WP4225,0.3747079327991494,1.6639367816091954,1.6333343257879673,"['NT5C', 'GLS2']",0.7823901636846239,0,0,2
251,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3873771122810297,1.2607718655234854,1.1956613324749934,"['IFNAR2', 'CD160', 'CXCL17', 'IRF7', 'CCL2']",0.7964134468244726,0,0,5
252,TGF-beta Signaling Pathway WP366,0.38763619290687595,1.1271647960415159,1.06820058095676,"['MAP2K3', 'KLF10', 'CDKN1A', 'SHC1', 'LIMK2', 'TNC', 'FN1', 'NEDD4L', 'PML', 'TGFBR3', 'KLF6', 'JUNB', 'MAP2K6']",0.7964134468244726,0,0,13
253,RANKL/RANK signaling pathway WP2018,0.3923111480132723,1.2177549729387784,1.1394533392710653,"['TNFRSF11B', 'NFATC1', 'TAB2', 'ICAM1', 'MAP2K6', 'NFKB2']",0.7964134468244726,0,0,6
254,AMP-activated protein kinase (AMPK) signaling WP1403,0.39550454983617345,1.1887939025646308,1.1027168879940674,"['CCNA2', 'SREBF1', 'CDKN1A', 'CRTC2', 'FASN', 'PIK3CD', 'SLC2A4']",0.7964134468244726,0,0,7
255,EPO Receptor Signaling WP581,0.3955839401974079,1.3866522885214474,1.2859706220400182,"['SHC1', 'IRS1', 'IRS2']",0.7964134468244726,0,0,3
256,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3955839401974079,1.3866522885214474,1.2859706220400182,"['TGFBR3', 'HGF', 'WNT5A']",0.7964134468244726,0,0,3
257,Unfolded protein response WP4925,0.3955839401974079,1.3866522885214474,1.2859706220400182,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.7964134468244726,0,0,3
258,Non-small cell lung cancer WP4255,0.3976112216822398,1.1679704311283259,1.0771964478715526,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PLCG2', 'PIK3CD', 'CYCS', 'RXRG']",0.7964134468244726,0,0,8
259,Gastrin signaling pathway WP4659,0.40038102958728794,1.1302143309856012,1.034528816214483,"['EGR1', 'CDKN1A', 'ANXA2', 'CCKBR', 'IRS1', 'SHC1', 'RPS6', 'PRKCQ', 'CD44', 'HDAC7', 'VEGFA']",0.7964134468244726,0,0,11
260,Bladder cancer WP2828,0.4047427180103882,1.2800221361372441,1.1577847299465245,"['CDKN1A', 'EGF', 'FGFR3', 'VEGFA']",0.7964134468244726,0,0,4
261,Glycogen Synthesis and Degradation WP500,0.4095581299653523,1.2235844661838817,1.0922650158247962,"['HKDC1', 'PYGM', 'CALM3', 'PYGL', 'GYG2']",0.7964134468244726,0,0,5
262,Canonical and non-canonical TGF-B signaling WP3874,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['BMP1', 'LOXL2']",0.7964134468244726,0,0,2
263,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['CCKBR', 'CD38']",0.7964134468244726,0,0,2
264,Cysteine and methionine catabolism WP4504,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['ETHE1', 'SQOR']",0.7964134468244726,0,0,2
265,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['RPH3AL', 'SYTL4']",0.7964134468244726,0,0,2
266,Omega-9 FA synthesis WP4724,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['SCD', 'FASN']",0.7964134468244726,0,0,2
267,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['NQO1', 'FN1']",0.7964134468244726,0,0,2
268,TP53 network WP1742,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['CDKN1A', 'GADD45A']",0.7964134468244726,0,0,2
269,Type II diabetes mellitus WP1584,0.41438389249195173,1.5125391849529781,1.3324902385930661,"['IRS1', 'SLC2A4']",0.7964134468244726,0,0,2
270,Hepatitis B infection WP4666,0.42559673438164813,1.088825680617635,0.9301435076010236,"['MAP2K3', 'CDKN1A', 'TICAM2', 'EGR3', 'NFATC2', 'PIK3CD', 'NFATC1', 'CREB3L4', 'IRF7', 'CYCS', 'FAS', 'TAB2', 'MYD88', 'MAP2K6']",0.7964134468244726,0,0,14
271,DNA Mismatch Repair WP531,0.42564233761177467,1.313557077452798,1.1219824862253587,"['POLE4', 'POLD4', 'RPA3']",0.7964134468244726,0,0,3
272,NRF2-ARE regulation WP4357,0.42564233761177467,1.313557077452798,1.1219824862253587,"['NQO1', 'CEBPB', 'GCLM']",0.7964134468244726,0,0,3
273,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.43329773735277816,2.0795046661880834,1.7391524954497861,['COX8A'],0.7964134468244726,0,0,1
274,Bile acids synthesis and enterohepatic circulation  WP4389,0.43329773735277816,2.0795046661880834,1.7391524954497861,['LDLR'],0.7964134468244726,0,0,1
275,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.43329773735277816,2.0795046661880834,1.7391524954497861,['HSD11B1'],0.7964134468244726,0,0,1
276,NAD Biosynthesis II (from tryptophan) WP2485,0.43329773735277816,2.0795046661880834,1.7391524954497861,['HAAO'],0.7964134468244726,0,0,1
277,Osteoblast Signaling WP322,0.43329773735277816,2.0795046661880834,1.7391524954497861,['TNFRSF11B'],0.7964134468244726,0,0,1
278,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.43329773735277816,2.0795046661880834,1.7391524954497861,['CD247'],0.7964134468244726,0,0,1
279,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.43329773735277816,2.0795046661880834,1.7391524954497861,['VEGFA'],0.7964134468244726,0,0,1
280,SARS-CoV-2 and COVID-19 Pathway WP4846,0.43329773735277816,2.0795046661880834,1.7391524954497861,['NRP1'],0.7964134468244726,0,0,1
281,Serotonin Transporter Activity WP1455,0.43329773735277816,2.0795046661880834,1.7391524954497861,['IL1R1'],0.7964134468244726,0,0,1
282,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.43329773735277816,2.0795046661880834,1.7391524954497861,['IGF1R'],0.7964134468244726,0,0,1
283,Tgif disruption of Shh signaling WP3674,0.43329773735277816,2.0795046661880834,1.7391524954497861,['TGIF2'],0.7964134468244726,0,0,1
284,Vitamin D Metabolism WP1531,0.43329773735277816,2.0795046661880834,1.7391524954497861,['DHCR7'],0.7964134468244726,0,0,1
285,Apoptosis WP254,0.4501984936016781,1.1199184737396706,0.8937696367760991,"['IRF7', 'TNFRSF10B', 'FAS', 'CYCS', 'IGF1R', 'TNFRSF1A', 'MCL1']",0.8177768244638275,0,0,7
286,Endometrial cancer WP4155,0.4501984936016781,1.1199184737396706,0.8937696367760991,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'FGF2', 'FGFR3']",0.8177768244638275,0,0,7
287,Proteasome Degradation WP183,0.4501984936016781,1.1199184737396706,0.8937696367760991,"['UBE2B', 'H2AFZ', 'NEDD4', 'HLA-B', 'HLA-C', 'HLA-E', 'PSMB9']",0.8177768244638275,0,0,7
288,Monoamine GPCRs WP58,0.45275383576637196,1.386374521072797,1.0985724732145938,"['HTR1E', 'DRD4']",0.8177768244638275,0,0,2
289,SARS coronavirus and innate immunity WP4912,0.45275383576637196,1.386374521072797,1.0985724732145938,"['IFNAR2', 'IRF9']",0.8177768244638275,0,0,2
290,Cell migration and invasion through p75NTR WP4561,0.45515860291537247,1.2477713874910137,0.9821325169403247,"['EFNA1', 'BDNF', 'PARD3']",0.8192854852476704,0,0,3
291,Cytosolic DNA-sensing pathway WP4655,0.47515630908808015,1.1240830463292666,0.8364430737475536,"['RNF125', 'IL18', 'IRF7', 'POLR2K', 'POLR2L']",0.8267663147468708,0,0,5
292,Pathogenic Escherichia coli infection WP2272,0.47515630908808015,1.1240830463292666,0.8364430737475536,"['TUBA1C', 'TUBB6', 'TUBB2B', 'TUBA1A', 'ACTG1']",0.8267663147468708,0,0,5
293,G Protein Signaling Pathways WP35,0.4781723173948415,1.0695100567302733,0.7890675304873359,"['AKAP12', 'AKAP13', 'GNA14', 'AKAP10', 'GNG3', 'PRKAR2B', 'PRKCQ', 'ADCY2', 'PDE8B']",0.8267663147468708,0,0,9
294,Amino Acid metabolism WP3925,0.4819496459974651,1.0733137829912023,0.783428516053316,"['PNMT', 'ARG2', 'LDHA', 'WARS', 'OAT', 'P4HA2', 'PYCR1', 'GCLM']",0.8267663147468708,0,0,8
295,16p11.2 distal deletion syndrome WP4950,0.48401677464206827,1.1882510013351135,0.8622373643766265,"['PLN', 'CD81', 'NFATC2']",0.8267663147468708,0,0,3
296,TYROBP causal network in microglia WP3945,0.48401677464206827,1.1882510013351135,0.8622373643766265,"['IL18', 'PPP1R18', 'IL13RA1']",0.8267663147468708,0,0,3
297,T-cell receptor (TCR) signaling pathway WP69,0.48615572769717247,1.0782530908702501,0.7776644645993731,"['SHC1', 'NFATC2', 'FAS', 'PRKCQ', 'NFATC1', 'CD247', 'MAP3K14']",0.8267663147468708,0,0,7
298,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.489640842987827,1.2796198054818744,0.9137549160724106,"['MAP2K3', 'MAP2K6']",0.8267663147468708,0,0,2
299,Constitutive Androstane Receptor Pathway WP2875,0.489640842987827,1.2796198054818744,0.9137549160724106,"['HSP90AA1', 'CYP3A5']",0.8267663147468708,0,0,2
300,ERK Pathway in Huntington's Disease WP3853,0.489640842987827,1.2796198054818744,0.9137549160724106,"['EGF', 'BDNF']",0.8267663147468708,0,0,2
301,MAPK pathway in congenital thyroid cancer WP4928,0.489640842987827,1.2796198054818744,0.9137549160724106,"['GAREM2', 'SHC1']",0.8267663147468708,0,0,2
302,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.489640842987827,1.2796198054818744,0.9137549160724106,"['ACTN1', 'PRKCQ']",0.8267663147468708,0,0,2
303,Overview of interferons-mediated signaling pathway WP4558,0.489640842987827,1.2796198054818744,0.9137549160724106,"['IFNAR2', 'IRF9']",0.8267663147468708,0,0,2
304,Notch Signaling Pathway Netpath WP61,0.4909341588191836,1.0849204360355844,0.7718614976485223,"['HES6', 'CDKN1A', 'NUMBL', 'NOTCH1', 'HES1', 'HES5']",0.8267663147468708,0,0,6
305,Aspirin and miRNAs WP4707,0.49415917663031356,1.6634601579325197,1.1725690627029413,['VEGFA'],0.8267663147468708,0,0,1
306,Caloric restriction and aging WP4191,0.49415917663031356,1.6634601579325197,1.1725690627029413,['NAMPT'],0.8267663147468708,0,0,1
307,Cytokines and Inflammatory Response WP530,0.49415917663031356,1.6634601579325197,1.1725690627029413,['CSF1'],0.8267663147468708,0,0,1
308,EDA signaling in hair follicle development WP3930,0.49415917663031356,1.6634601579325197,1.1725690627029413,['BMP1'],0.8267663147468708,0,0,1
309,Genes targeted by miRNAs in adipocytes WP1992,0.49415917663031356,1.6634601579325197,1.1725690627029413,['TMSB4X'],0.8267663147468708,0,0,1
310,HIF1A and PPARG regulation of glycolysis WP2456,0.49415917663031356,1.6634601579325197,1.1725690627029413,['LDHA'],0.8267663147468708,0,0,1
311,LDLRAD4 and what we know about it WP4904,0.49415917663031356,1.6634601579325197,1.1725690627029413,['NEDD4'],0.8267663147468708,0,0,1
312,Urea cycle and related diseases WP4571,0.49415917663031356,1.6634601579325197,1.1725690627029413,['GLS2'],0.8267663147468708,0,0,1
313,B Cell Receptor Signaling Pathway WP23,0.4985185825311517,1.056185437137818,0.7352259059958328,"['BCL6', 'CD81', 'SHC1', 'INPP5D', 'PLCG2', 'GAB1', 'NFATC2', 'MAP2K6']",0.831395207927352,0,0,8
314,Integrated breast cancer pathway WP1984,0.500503686860065,1.0304732589457484,0.7132320849124899,"['BARD1', 'SMAD1', 'PLK3', 'ANXA1', 'IRS1', 'GADD45A', 'PML', 'FOSL2', 'VEGFA', 'ITPKC', 'RASGEF1A', 'CHEK2', 'FILIP1', 'FAU']",0.8314136476651625,0,0,14
315,DNA Replication WP466,0.5033078786632018,1.108968824940048,0.7613661080079369,"['POLD4', 'PRIM1', 'RPA3', 'CDC7']",0.8314136476651625,0,0,4
316,Prader-Willi and Angelman Syndrome WP3998,0.5033078786632018,1.108968824940048,0.7613661080079369,"['PCSK1', 'CCND2', 'BDNF', 'GNRH1']",0.8314136476651625,0,0,4
317,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.512119743935749,1.1341415593752042,0.7589639095536753,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.840649390988871,0,0,3
318,Resistin as a regulator of inflammation WP4481,0.512119743935749,1.1341415593752042,0.7589639095536753,"['PLCG2', 'PIK3CD', 'PLCE1']",0.840649390988871,0,0,3
319,Nanomaterial induced apoptosis WP2507,0.5249209743283224,1.188115763546798,0.7657495832178912,"['FAS', 'CYCS']",0.8516879214321569,0,0,2
320,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5249209743283224,1.188115763546798,0.7657495832178912,"['BCL2L14', 'MCL1']",0.8516879214321569,0,0,2
321,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5386893079506435,1.0212373037857803,0.6317540395999338,"['SREBF1', 'SQLE', 'RBP4', 'SCD', 'FASN', 'DBI', 'LDLR']",0.8516879214321569,0,0,7
322,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.539387863150139,1.084737286281374,0.6696304220286442,"['RAB13', 'NDRG1', 'TEAD3']",0.8516879214321569,0,0,3
323,Oxysterols derived from cholesterol WP4545,0.539387863150139,1.084737286281374,0.6696304220286442,"['CYP39A1', 'HSD3B7', 'DHCR7']",0.8516879214321569,0,0,3
324,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.539387863150139,1.084737286281374,0.6696304220286442,"['LDHA', 'MCL1', 'VEGFA']",0.8516879214321569,0,0,3
325,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.539387863150139,1.084737286281374,0.6696304220286442,"['CREB3L4', 'CAMK4', 'CALM3']",0.8516879214321569,0,0,3
326,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.5484885224774367,1.3860971524288108,0.8324745984145252,['NFKB2'],0.8516879214321569,0,0,1
327,"Cerebral organic acidurias, including diseases WP4519",0.5484885224774367,1.3860971524288108,0.8324745984145252,['ADHFE1'],0.8516879214321569,0,0,1
328,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.5484885224774367,1.3860971524288108,0.8324745984145252,['CEBPB'],0.8516879214321569,0,0,1
329,Glial Cell Differentiation WP2276,0.5484885224774367,1.3860971524288108,0.8324745984145252,['GAP43'],0.8516879214321569,0,0,1
330,Methylation Pathways WP704,0.5484885224774367,1.3860971524288108,0.8324745984145252,['PNMT'],0.8516879214321569,0,0,1
331,Nephrogenesis WP5052,0.5484885224774367,1.3860971524288108,0.8324745984145252,['RSPO3'],0.8516879214321569,0,0,1
332,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5484885224774367,1.3860971524288108,0.8324745984145252,['MUC1'],0.8516879214321569,0,0,1
333,Role of Osx and miRNAs in tooth development WP3971,0.5484885224774367,1.3860971524288108,0.8324745984145252,['NOTCH1'],0.8516879214321569,0,0,1
334,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5484885224774367,1.3860971524288108,0.8324745984145252,['CXCR4'],0.8516879214321569,0,0,1
335,Type III interferon signaling WP2113,0.5484885224774367,1.3860971524288108,0.8324745984145252,['IRF9'],0.8516879214321569,0,0,1
336,Hedgehog Signaling Pathway WP4249,0.5498445010012201,1.039478417266187,0.621732587886823,"['EVC2', 'CCND2', 'BOC', 'GLI2']",0.8516879214321569,0,0,4
337,IL-6 signaling pathway WP364,0.5498445010012201,1.039478417266187,0.621732587886823,"['SOCS3', 'SHC1', 'GAB1', 'JUNB']",0.8516879214321569,0,0,4
338,Mesodermal commitment pathway WP2857,0.55462769886848,0.9941290200886541,0.5859975059114451,"['SMAD1', 'FZD5', 'FZD4', 'TRIM5', 'SESN1', 'BHLHE40', 'PBX3', 'ARID5B', 'HMGA2', 'RPL38', 'TBX6']",0.8549685638381666,0,0,11
339,Gastric Cancer Network 1 WP2361,0.5585139468751241,1.1088122605363984,0.6458561851627781,"['NOTCH1', 'GATD3A']",0.8549685638381666,0,0,2
340,Nucleotide metabolism WP404,0.5585139468751241,1.1088122605363984,0.6458561851627781,"['NME2', 'OAZ1']",0.8549685638381666,0,0,2
341,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5585139468751241,1.1088122605363984,0.6458561851627781,"['FGF2', 'GLI2']",0.8549685638381666,0,0,2
342,BDNF-TrkB Signaling WP3676,0.5657574945548877,1.0394500359453631,0.5920600834526777,"['SHC1', 'BDNF', 'GAB1']",0.8604048874855804,0,0,3
343,Lipid Metabolism Pathway WP3965,0.5657574945548877,1.0394500359453631,0.5920600834526777,"['PRKAR2B', 'FASN', 'HILPDA']",0.8604048874855804,0,0,3
344,Ras signaling WP4223,0.5670101174234476,0.9818823408495257,0.5570985680348882,"['SHC1', 'GAB1', 'PIK3CD', 'PLA2G5', 'IGF1R', 'GNG3', 'MRAS', 'RASA4', 'PLCG2', 'PLCE1', 'CALM3', 'RALGDS', 'FGFR3', 'EPHA2', 'ARF6']",0.8604048874855804,0,0,15
345,Copper homeostasis WP3286,0.5722321970816858,1.007891868323523,0.5626157542376902,"['STEAP3', 'STEAP4', 'SOD3', 'ATOX1']",0.8633098464642774,0,0,4
346,TGF-beta Receptor Signaling WP560,0.5722321970816858,1.007891868323523,0.5626157542376902,"['TGFBR3', 'SMAD1', 'EGF', 'SMAD9']",0.8633098464642774,0,0,4
347,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.5903752006051053,1.0394216954022988,0.5477721266177391,"['ETV6', 'MCL1']",0.8680415014708619,0,0,2
348,NAD+ biosynthetic pathways WP3645,0.5903752006051053,1.0394216954022988,0.5477721266177391,"['NAMPT', 'CD38']",0.8680415014708619,0,0,2
349,One-carbon metabolism WP241,0.5903752006051053,1.0394216954022988,0.5477721266177391,"['CHDH', 'GLRX']",0.8680415014708619,0,0,2
350,Purinergic signaling WP4900,0.5903752006051053,1.0394216954022988,0.5477721266177391,"['P2RY12', 'P2RY14']",0.8680415014708619,0,0,2
351,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5911795435408042,0.9977857656362329,0.524471631322962,"['IFNAR2', 'IRF9', 'MYD88']",0.8680415014708619,0,0,3
352,Nuclear receptors WP170,0.5911795435408042,0.9977857656362329,0.524471631322962,"['NR4A1', 'ESRRB', 'RXRG']",0.8680415014708619,0,0,3
353,IL-3 signaling pathway WP286,0.5939798397329945,0.9781633516716038,0.5095349737409757,"['SHC1', 'INPP5D', 'PIK3CD', 'ENPP3']",0.8680415014708619,0,0,4
354,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5969863966054395,1.1879807199261614,0.6128328652631257,['ELOB'],0.8680415014708619,0,0,1
355,LTF danger signal response pathway WP4478,0.5969863966054395,1.1879807199261614,0.6128328652631257,['MYD88'],0.8680415014708619,0,0,1
356,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5969863966054395,1.1879807199261614,0.6128328652631257,['CLDN4'],0.8680415014708619,0,0,1
357,Osteoclast Signaling WP12,0.5969863966054395,1.1879807199261614,0.6128328652631257,['TNFRSF11B'],0.8680415014708619,0,0,1
358,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5969863966054395,1.1879807199261614,0.6128328652631257,['ANAPC11'],0.8680415014708619,0,0,1
359,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5969863966054395,1.1879807199261614,0.6128328652631257,['MYD88'],0.8680415014708619,0,0,1
360,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6204891626658614,0.9781947261663286,0.46684063540260456,"['BCL6', 'H2AFZ']",0.8865392142019196,0,0,2
361,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6204891626658614,0.9781947261663286,0.46684063540260456,"['BDNF', 'RPS6']",0.8865392142019196,0,0,2
362,Hippo-Yap signaling pathway WP4537,0.6204891626658614,0.9781947261663286,0.46684063540260456,"['NDRG1', 'TEAD3']",0.8865392142019196,0,0,2
363,Kallmann's Syndrome WP5074,0.6204891626658614,0.9781947261663286,0.46684063540260456,"['GNRH1', 'PRKCQ']",0.8865392142019196,0,0,2
364,Sleep regulation WP3591,0.6204891626658614,0.9781947261663286,0.46684063540260456,"['OXTR', 'IL18']",0.8865392142019196,0,0,2
365,Kit receptor signaling pathway WP304,0.6345197510814224,0.9236061115110791,0.4201362873929143,"['KITLG', 'SHC1', 'INPP5D', 'RPS6', 'JUNB']",0.8865392142019196,0,0,5
366,Melanoma WP4685,0.6349838702902536,0.9235510726865194,0.41943596684349643,"['GRM3', 'CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'CALM3']",0.8865392142019196,0,0,6
367,Corticotropin-releasing hormone signaling pathway WP2355,0.6362307654586865,0.9234959544981174,0.4175992767140543,"['NR4A1', 'HSP90AA1', 'IL18', 'PLCG2', 'PRKCQ', 'JUNB', 'FOSL2']",0.8865392142019196,0,0,7
368,Hippo-Merlin Signaling Dysregulation WP4541,0.6379483138953782,0.9234407567740901,0.4150847840208738,"['CDH4', 'PRKAR2B', 'ITGA3', 'FGFR3', 'CD44', 'IGF1R', 'EPHA2', 'TEAD3']",0.8865392142019196,0,0,8
369,ATM Signaling Pathway WP2516,0.6390485781940493,0.923715951753335,0.41361673043151986,"['CDKN1A', 'GADD45A', 'CHEK2']",0.8865392142019196,0,0,3
370,Neural Crest Cell Migration during Development WP4564,0.6390485781940493,0.923715951753335,0.41361673043151986,"['BDNF', 'PIK3CD', 'EPHB1']",0.8865392142019196,0,0,3
371,15q13.3 copy number variation syndrome WP4942,0.6402783213680531,1.0393933955491745,0.46341595682165676,['CHRNA7'],0.8865392142019196,0,0,1
372,Cancer immunotherapy by CTLA4 blockade WP4582,0.6402783213680531,1.0393933955491745,0.46341595682165676,['PIK3CD'],0.8865392142019196,0,0,1
373,"Degradation pathway of sphingolipids, including diseases WP4153",0.6402783213680531,1.0393933955491745,0.46341595682165676,['NEU4'],0.8865392142019196,0,0,1
374,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6402783213680531,1.0393933955491745,0.46341595682165676,['PRKCQ'],0.8865392142019196,0,0,1
375,NLR Proteins WP288,0.6402783213680531,1.0393933955491745,0.46341595682165676,['ERBIN'],0.8865392142019196,0,0,1
376,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6402783213680531,1.0393933955491745,0.46341595682165676,['CCND2'],0.8865392142019196,0,0,1
377,Trans-sulfuration pathway WP2333,0.6402783213680531,1.0393933955491745,0.46341595682165676,['GCLM'],0.8865392142019196,0,0,1
378,7-oxo-C and 7beta-HC pathways WP5064,0.6488635449996074,0.9237707535121328,0.3995611862530126,"['HSD11B1', 'DHCR7']",0.8905351650588116,0,0,2
379,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6488635449996074,0.9237707535121328,0.3995611862530126,"['CEBPB', 'ATP2C2']",0.8905351650588116,0,0,2
380,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6488635449996074,0.9237707535121328,0.3995611862530126,"['NAMPT', 'SLC2A4']",0.8905351650588116,0,0,2
381,22q11.2 copy number variation syndrome WP4657,0.6520504588869218,0.9107118148214038,0.3894507252402162,"['ACTA2', 'SREBF1', 'AIFM3', 'OAT', 'THAP7', 'HIST1H4H', 'HES1', 'SLC2A4']",0.8905351650588116,0,0,8
382,Modulators of TCR signaling and T cell activation WP5072,0.6551063283191257,0.8986194827921447,0.3800780504737956,"['ELOB', 'PRKCQ', 'CD247', 'MAP3K14']",0.8905351650588116,0,0,4
383,Phosphodiesterases in neuronal function WP4222,0.6551063283191257,0.8986194827921447,0.3800780504737956,"['CHRNA7', 'PDE5A', 'ADCY2', 'PDE8B']",0.8905351650588116,0,0,4
384,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6551063283191257,0.8986194827921447,0.3800780504737956,"['TGFBR3', 'SMAD1', 'EGF', 'SMAD9']",0.8905351650588116,0,0,4
385,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6614572796105609,0.8906490705556126,0.3681140592266877,"['NFATC2', 'NFATC1', 'HDAC7']",0.8945095853800848,0,0,3
386,Vitamin D-sensitive calcium signaling in depression WP4698,0.6614572796105609,0.8906490705556126,0.3681140592266877,"['CALB1', 'ATP2B4', 'PVALB']",0.8945095853800848,0,0,3
387,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6755245305508002,0.8750756200846945,0.3432622448098107,"['CDKN1A', 'FGFR3']",0.9001062358544369,0,0,2
388,SARS-CoV-2 mitochondrial interactions WP5038,0.6755245305508002,0.8750756200846945,0.3432622448098107,"['IRF7', 'NFKB2']",0.9001062358544369,0,0,2
389,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.6789227646682433,0.9238254765892957,0.35774948181841165,['SMAD1'],0.9001062358544369,0,0,1
390,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.6789227646682433,0.9238254765892957,0.35774948181841165,['PRKCQ'],0.9001062358544369,0,0,1
391,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6789227646682433,0.9238254765892957,0.35774948181841165,['ADCY2'],0.9001062358544369,0,0,1
392,Osteopontin Signaling WP1434,0.6789227646682433,0.9238254765892957,0.35774948181841165,['MAP3K14'],0.9001062358544369,0,0,1
393,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6789227646682433,0.9238254765892957,0.35774948181841165,['SAMHD1'],0.9001062358544369,0,0,1
394,Pathways Regulating Hippo Signaling WP4540,0.6802784075591434,0.8812894627602631,0.3395195342945055,"['CDH4', 'PRKAR2B', 'PRKCQ', 'FGFR3', 'IGF1R', 'EPHA2', 'TEAD3']",0.9001062358544369,0,0,7
395,Amyotrophic lateral sclerosis (ALS) WP2447,0.6828392134068143,0.8598626639232505,0.32803404595130414,"['SLC1A2', 'MAP2K6', 'TNFRSF1A']",0.9001062358544369,0,0,3
396,p38 MAPK Signaling Pathway WP400,0.6828392134068143,0.8598626639232505,0.32803404595130414,"['SHC1', 'HSPB1', 'MAP2K6']",0.9001062358544369,0,0,3
397,AGE/RAGE pathway WP2324,0.6859892895163818,0.8656557475401968,0.3262598204747336,"['LGALS3', 'IRS1', 'SHC1', 'CYCS', 'MYD88']",0.901980879414487,0,0,5
398,Pre-implantation embryo WP3527,0.7005127235074349,0.83125,0.29587741085831526,"['EGR1', 'ZFP36']",0.9105241191231734,0,0,2
399,Trans-sulfuration and one-carbon metabolism WP2525,0.7005127235074349,0.83125,0.29587741085831526,"['AHCYL1', 'GCLM']",0.9105241191231734,0,0,2
400,Neural Crest Cell Migration in Cancer WP4565,0.7031973611654031,0.8311286843997124,0.29265510847670245,"['BDNF', 'PIK3CD', 'EPHB1']",0.9105241191231734,0,0,3
401,Alanine and aspartate metabolism WP106,0.7134183232210305,0.8313711414213927,0.2807434943588968,['GPT'],0.9105241191231734,0,0,1
402,Biomarkers for pyrimidine metabolism disorders WP4584,0.7134183232210305,0.8313711414213927,0.2807434943588968,['NT5C'],0.9105241191231734,0,0,1
403,Dopaminergic Neurogenesis WP2855,0.7134183232210305,0.8313711414213927,0.2807434943588968,['GLI2'],0.9105241191231734,0,0,1
404,Ganglio Sphingolipid Metabolism WP1423,0.7134183232210305,0.8313711414213927,0.2807434943588968,['ST8SIA1'],0.9105241191231734,0,0,1
405,GDNF/RET signaling axis WP4830,0.7134183232210305,0.8313711414213927,0.2807434943588968,['IFT27'],0.9105241191231734,0,0,1
406,Glycolysis in senescence WP5049,0.7134183232210305,0.8313711414213927,0.2807434943588968,['LDHA'],0.9105241191231734,0,0,1
407,Homologous recombination WP186,0.7134183232210305,0.8313711414213927,0.2807434943588968,['POLD4'],0.9105241191231734,0,0,1
408,"NAD metabolism, sirtuins and aging WP3630",0.7134183232210305,0.8313711414213927,0.2807434943588968,['NAMPT'],0.9105241191231734,0,0,1
409,RalA downstream regulated genes WP2290,0.7134183232210305,0.8313711414213927,0.2807434943588968,['YBX3'],0.9105241191231734,0,0,1
410,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7225414833759443,0.8042485100067253,0.26136503803441524,"['CCL2', 'MAP3K14', 'NFKB2']",0.9149279235745919,0,0,3
411,Endothelin Pathways WP2197,0.7238797556251081,0.7915982484948002,0.25578912919681995,"['EDNRA', 'CALCRL']",0.9149279235745919,0,0,2
412,MTHFR deficiency WP4288,0.7238797556251081,0.7915982484948002,0.25578912919681995,"['CHDH', 'CYCS']",0.9149279235745919,0,0,2
413,Photodynamic therapy-induced unfolded protein response WP3613,0.7238797556251081,0.7915982484948002,0.25578912919681995,"['XBP1', 'WARS']",0.9149279235745919,0,0,2
414,Pancreatic adenocarcinoma pathway WP4263,0.7334981327304599,0.8306416726748378,0.2574409622511842,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'RALGDS', 'VEGFA']",0.9231047912552776,0,0,7
415,Regulation of Actin Cytoskeleton WP51,0.7338859930477781,0.85365013076003,0.26412070370999335,"['MRAS', 'EGF', 'ACTN1', 'TMSB4X', 'FN1', 'PIP4K2A', 'PIK3CD', 'PIK3C2A', 'FGF2', 'FGFR3', 'ACTG1']",0.9231047912552776,0,0,11
416,Integrated Cancer Pathway WP1971,0.7408871056028932,0.7790483465132998,0.23364206757540912,"['BARD1', 'CDKN1A', 'CHEK2']",0.9274414127690893,0,0,3
417,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7408871056028932,0.7790483465132998,0.23364206757540912,"['ACTA2', 'ACTG1', 'TEAD3']",0.9274414127690893,0,0,3
418,Cell Differentiation - Index expanded WP2023,0.7442101370002515,0.7557266853749266,0.22326572657563187,['ID2'],0.9293724677371562,0,0,1
419,Male infertility WP4673,0.7691583133684293,0.7962983081648576,0.20899522887585828,"['NQO1', 'UBE2B', 'PON1', 'FAS', 'TEX15', 'SOD2', 'SOD3']",0.9500592265235607,0,0,7
420,Hedgehog Signaling Pathway Netpath WP47,0.7716956169463405,0.6926896386695381,0.17952096927317393,['GLI2'],0.9500592265235607,0,0,1
421,Omega-3/Omega-6 FA synthesis WP4723,0.7716956169463405,0.6926896386695381,0.17952096927317393,['PLA2G5'],0.9500592265235607,0,0,1
422,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7716956169463405,0.6926896386695381,0.17952096927317393,['LDHA'],0.9500592265235607,0,0,1
423,PPAR-alpha pathway WP2878,0.7716956169463405,0.6926896386695381,0.17952096927317393,['DBI'],0.9500592265235607,0,0,1
424,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7716956169463405,0.6926896386695381,0.17952096927317393,['F3'],0.9500592265235607,0,0,1
425,Common Pathways Underlying Drug Addiction WP2636,0.7746683113916077,0.7330951072017592,0.18717408215694195,"['CAMK4', 'DRD4', 'ACTG1']",0.9514749612856923,0,0,3
426,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7848794275580778,0.6924688697318008,0.1677333886269561,"['PIK3CD', 'PRKCQ']",0.959501314251327,0,0,2
427,Nanoparticle-mediated activation of receptor signaling WP2643,0.7848794275580778,0.6924688697318008,0.1677333886269561,"['FN1', 'PIK3CD']",0.959501314251327,0,0,2
428,ErbB signaling pathway WP673,0.7909140855624952,0.77492910358087,0.1817719674764013,"['CDKN1A', 'SHC1', 'EGF', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1']",0.9646195155692114,0,0,7
429,Airway smooth muscle cell contraction WP4962,0.7962295593365788,0.6393505991495941,0.14568737838993462,['CD38'],0.9688387645074457,0,0,1
430,Chemokine signaling pathway WP3929,0.7985579723790194,0.786349990499715,0.17688763147773848,"['GNG3', 'GRK5', 'SHC1', 'PARD3', 'PIK3CD', 'CXCR4', 'PRKX', 'ADCY2', 'CCR10']",0.9694122362368561,0,0,9
431,Metabolic reprogramming in colon cancer WP4290,0.804747455644704,0.6922477833692787,0.15037475035318612,"['LDHA', 'FASN', 'PYCR1']",0.9701574407541236,0,0,3
432,Netrin-UNC5B signaling pathway WP4747,0.804747455644704,0.6922477833692787,0.15037475035318612,"['INPP5D', 'CCL2', 'ICAM1']",0.9701574407541236,0,0,3
433,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.804747455644704,0.6922477833692787,0.15037475035318612,"['NFATC2', 'PRKCQ', 'MAP3K14']",0.9701574407541236,0,0,3
434,ATM Signaling Network in Development and Disease  WP3878,0.8184752127975501,0.6734800940408417,0.13490625661218458,"['CHEK2', 'HSPB1', 'CDK5R1']",0.9708513730976442,0,0,3
435,Interleukin-11 Signaling Pathway WP2332,0.8184752127975501,0.6734800940408417,0.13490625661218458,"['SOCS3', 'RPS6', 'ICAM1']",0.9708513730976442,0,0,3
436,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.831028608102922,0.7035911703334919,0.13022843454048308,"['CDKN1A', 'GADD45B', 'GADD45A', 'CYCS', 'RALGDS']",0.9708513730976442,0,0,5
437,Base Excision Repair WP4752,0.8336974930414832,0.6153682418050234,0.11192604380301384,"['POLE4', 'POLD4']",0.9708513730976442,0,0,2
438,Development of ureteric collection system WP5053,0.8336974930414832,0.6153682418050234,0.11192604380301384,"['SMAD1', 'GLI2']",0.9708513730976442,0,0,2
439,Acute viral myocarditis WP4298,0.8350334169339354,0.6778446630450742,0.12220423179869852,"['LAMA2', 'CXCR4', 'CYCS', 'NFKB2']",0.9708513730976442,0,0,4
440,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8350334169339354,0.6778446630450742,0.12220423179869852,"['GHR', 'IFNAR2', 'SOCS3', 'OSMR']",0.9708513730976442,0,0,4
441,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.837675853663438,0.5540081359176836,0.09812817185853343,['PLA2G5'],0.9708513730976442,0,0,1
442,"Relationship between inflammation, COX-2 and EGFR WP4483",0.837675853663438,0.5540081359176836,0.09812817185853343,['PIK3CD'],0.9708513730976442,0,0,1
443,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.837675853663438,0.5540081359176836,0.09812817185853343,['EGR1'],0.9708513730976442,0,0,1
444,Transcription co-factors SKI and SKIL protein partners WP4533,0.837675853663438,0.5540081359176836,0.09812817185853343,['TEAD3'],0.9708513730976442,0,0,1
445,Triacylglyceride synthesis WP325,0.837675853663438,0.5540081359176836,0.09812817185853343,['MOGAT1'],0.9708513730976442,0,0,1
446,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8434745797511247,0.6388320522037273,0.10874551449842228,"['ADCY2', 'EMD', 'SYNE2']",0.9708513730976442,0,0,3
447,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8434745797511247,0.6388320522037273,0.10874551449842228,"['MAP1LC3A', 'CP', 'FTL']",0.9708513730976442,0,0,3
448,EGF/EGFR signaling pathway WP437,0.8471006199886444,0.7655126349771791,0.12702594816463708,"['PTPRR', 'PLSCR1', 'SHC1', 'EGF', 'RPS6KA2', 'INPP5D', 'LIMK2', 'NEDD4', 'GAB1', 'PLCE1', 'RALGDS', 'ARF6']",0.9708513730976442,0,0,12
449,DNA IR-damage and cellular response via ATR WP4016,0.8504492151693481,0.6804045840267204,0.11021913365298866,"['BARD1', 'SEM1', 'BCL6', 'CHEK2', 'PML']",0.9708513730976442,0,0,5
450,Leptin signaling pathway WP2034,0.8504492151693481,0.6804045840267204,0.11021913365298866,"['SOCS3', 'IRS1', 'SHC1', 'RPS6', 'PLCG2']",0.9708513730976442,0,0,5
451,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8548158863144784,0.6228073328540619,0.09769926992139406,"['XBP1', 'MAP1LC3A', 'PPP1R3C']",0.9708513730976442,0,0,3
452,7q11.23 copy number variation syndrome WP4932,0.8549247715808944,0.7083457892978353,0.11102739430011836,"['CLIP2', 'SNAP25', 'CLDN4', 'FZD9', 'FAS', 'NRG1', 'HSPA2']",0.9708513730976442,0,0,7
453,Methionine De Novo and Salvage Pathway WP3580,0.8551234315813876,0.51933776022972,0.08128127035574965,['CHDH'],0.9708513730976442,0,0,1
454,Mitochondrial Gene Expression WP391,0.8551234315813876,0.51933776022972,0.08128127035574965,['CAMK4'],0.9708513730976442,0,0,1
455,MET in type 1 papillary renal cell carcinoma WP4205,0.8557319956115172,0.6511496685004937,0.10144784281655779,"['CDKN1A', 'HGF', 'GAB1', 'PIK3CD']",0.9708513730976442,0,0,4
456,Integrin-mediated Cell Adhesion WP185,0.8644296910156549,0.6820496624689116,0.09936461394769408,"['MAP2K3', 'VASP', 'CAV3', 'SHC1', 'ITGA3', 'MAP2K6']",0.9708513730976442,0,0,6
457,Pathways affected in adenoid cystic carcinoma WP3651,0.8652253747532126,0.6385722191477587,0.09244307150711077,"['NOTCH1', 'CHEK2', 'ERBIN', 'ARID5B']",0.9708513730976442,0,0,4
458,Nucleotide Excision Repair WP4753,0.8654320054458965,0.6075643071312093,0.08780912367316962,"['POLE4', 'POLD4', 'RPA3']",0.9708513730976442,0,0,3
459,Alzheimer's disease WP2059,0.8679793629717955,0.6586901619299027,0.09326218790032445,"['FAS', 'CYCS', 'CALM3', 'TNFRSF1A', 'CDK5R1']",0.9708513730976442,0,0,5
460,Thermogenesis WP4321,0.8699791068039442,0.6913602499399183,0.09629686101067832,"['MAP2K3', 'CREB3L4', 'RPS6KA2', 'RPS6', 'ACSL6', 'ADCY2', 'ACTG1']",0.9708513730976442,0,0,7
461,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8706968157857896,0.4887462522697521,0.06767251488282593,['SREBF1'],0.9708513730976442,0,0,1
462,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.8706968157857896,0.4887462522697521,0.06767251488282593,['MCL1'],0.9708513730976442,0,0,1
463,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8706968157857896,0.4887462522697521,0.06767251488282593,['MAP1LC3A'],0.9708513730976442,0,0,1
464,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8706968157857896,0.4887462522697521,0.06767251488282593,['MRAS'],0.9708513730976442,0,0,1
465,IL-5 signaling pathway WP127,0.872278340963209,0.5536877394636015,0.07565960666598134,"['SHC1', 'RPS6']",0.9708513730976442,0,0,2
466,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.872278340963209,0.5536877394636015,0.07565960666598134,"['SHC1', 'BDNF']",0.9708513730976442,0,0,2
467,NO/cGMP/PKG mediated Neuroprotection WP4008,0.872278340963209,0.5536877394636015,0.07565960666598134,"['ACTN2', 'CYCS']",0.9708513730976442,0,0,2
468,Signaling of Hepatocyte Growth Factor Receptor WP313,0.872278340963209,0.5536877394636015,0.07565960666598134,"['HGF', 'GAB1']",0.9708513730976442,0,0,2
469,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.872278340963209,0.5536877394636015,0.07565960666598134,"['RPS6', 'NFKB2']",0.9708513730976442,0,0,2
470,MAPK Cascade WP422,0.8831867618358171,0.53578049684835,0.06655389917266559,"['MAP2K3', 'MAP2K6']",0.9762718112526956,0,0,2
471,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8845971999385481,0.46155380074978064,0.05659705581278813,['GNA14'],0.9762718112526956,0,0,1
472,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8845971999385481,0.46155380074978064,0.05659705581278813,['NFATC2'],0.9762718112526956,0,0,1
473,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8846294381657567,0.5792051895072977,0.07100269966061597,"['BDNF', 'CAMK4', 'PIK3CD']",0.9762718112526956,0,0,3
474,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8932800808991969,0.5659924187961571,0.06387513490285918,"['DDX3Y', 'RNF125', 'IRF7']",0.9834373177833784,0,0,3
475,Glycerolipids and Glycerophospholipids WP4722,0.897004193620457,0.4372237125477009,0.04752391853201562,['PNPLA3'],0.9834373177833784,0,0,1
476,Signal Transduction of S1P Receptor WP26,0.897004193620457,0.4372237125477009,0.04752391853201562,['S1PR3'],0.9834373177833784,0,0,1
477,Rett syndrome causing genes WP4312,0.9013438042061452,0.5533668823388449,0.05747739546777738,"['HAP1', 'SMARCA1', 'SYNE2']",0.9834373177833784,0,0,3
478,G13 Signaling Pathway WP524,0.9024597577050081,0.5032218739115291,0.05164625450486581,"['PIK3CD', 'PIP4K2A']",0.9834373177833784,0,0,2
479,Pathways in clear cell renal cell carcinoma WP4018,0.9043525369996762,0.6099923770804218,0.061326205854402044,"['LDHA', 'FASN', 'ENPP3', 'PFKP', 'VEGFA']",0.9834373177833784,0,0,5
480,Cannabinoid receptor signaling WP3869,0.9080781363440391,0.41532663316582913,0.04004780865325904,['PRKAR2B'],0.9834373177833784,0,0,1
481,Nanoparticle triggered autophagic cell death WP2509,0.9080781363440391,0.41532663316582913,0.04004780865325904,['MAP1LC3A'],0.9834373177833784,0,0,1
482,Sphingolipid Metabolism (general overview) WP4725,0.9080781363440391,0.41532663316582913,0.04004780865325904,['UGCG'],0.9834373177833784,0,0,1
483,Endoderm differentiation WP2853,0.9128408658865991,0.6377904719649492,0.05816248037562654,"['MAP2K3', 'NOTCH1', 'TRIM5', 'SESN1', 'PBX3', 'GLI2', 'NME1']",0.9865485134426599,0,0,7
484,Oxidative phosphorylation WP623,0.9158406972386297,0.5297275800357925,0.04656985638132338,"['NDUFA7', 'NDUFA4', 'NDUFB2']",0.9877455453689354,0,0,3
485,Sphingolipid Metabolism (integrated pathway) WP4726,0.9179621635207066,0.3955149899155642,0.03385572931675052,['UGCG'],0.9879922667171316,0,0,1
486,Ethanol effects on histone modifications WP3996,0.9267840514686853,0.3775044051425961,0.028703432208508146,['HDAC7'],0.9913550714480609,0,0,1
487,Gastric Cancer Network 2 WP2363,0.9267840514686853,0.3775044051425961,0.028703432208508146,['S100A6'],0.9913550714480609,0,0,1
488,Physiological and pathological hypertrophy of the heart WP1528,0.9267840514686853,0.3775044051425961,0.028703432208508146,['MAP2K3'],0.9913550714480609,0,0,1
489,16p11.2 proximal deletion syndrome WP4949,0.9340397204363852,0.5351125551171966,0.03651410856306499,"['MAP2K3', 'MVP', 'TBX6', 'MAP2K6']",0.9936688497514772,0,0,4
490,Glycerophospholipid Biosynthetic Pathway WP2533,0.9346578644214086,0.36105995817597303,0.02439853173792439,['PIK3CD'],0.9936688497514772,0,0,1
491,Sphingolipid pathway WP1422,0.9346578644214086,0.36105995817597303,0.02439853173792439,['UGCG'],0.9936688497514772,0,0,1
492,Histone Modifications WP2369,0.9384167073760411,0.43681941923774953,0.027764756725572853,"['SETBP1', 'HIST1H4H']",0.9956372383136046,0,0,2
493,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9432007712879446,0.5183003597122302,0.0303081898966119,"['SLCO1C1', 'NOTCH1', 'RPS6', 'PRKCQ']",0.9986831695990002,0,0,4
494,Eukaryotic Transcription Initiation WP405,0.9489276631930491,0.4149066091954023,0.021750527822291976,"['POLR2I', 'POLR2K']",0.9999957779687216,0,0,2
495,Intraflagellar transport proteins binding to dynein WP4532,0.9535556074558146,0.31931636202992986,0.015185899490793913,['IFT27'],0.9999957779687216,0,0,1
496,miRNA regulation of prostate cancer signaling pathways WP3981,0.9630108408465293,0.29645677366423956,0.0111736366019245,['CDKN1A'],0.9999957779687216,0,0,1
497,PDGFR-beta pathway WP3972,0.9630108408465293,0.29645677366423956,0.0111736366019245,['SHC1'],0.9999957779687216,0,0,1
498,Prion disease pathway WP3995,0.9630108408465293,0.29645677366423956,0.0111736366019245,['EBF1'],0.9999957779687216,0,0,1
499,Proximal tubule transport WP4917,0.9630108408465293,0.29645677366423956,0.0111736366019245,['SLC22A6'],0.9999957779687216,0,0,1
500,Fatty acid beta-oxidation WP143,0.9669904565308236,0.28620937198306806,0.009607090597057241,['ACSL6'],0.9999957779687216,0,0,1
501,Tumor suppressor activity of SMARCB1 WP4204,0.970542156163055,0.27664513041397465,0.008271811052703028,['GLI2'],0.9999957779687216,0,0,1
502,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.97296618027259,0.5471479851645141,0.014995113387495073,"['EGR1', 'IRS1', 'SHC1', 'BDNF', 'CAMK4', 'RPS6', 'IRS2', 'CDK5R1']",0.9999957779687216,0,0,8
503,Translation Factors WP107,0.9737871480134483,0.3528980190755686,0.009373865308632554,"['EIF4A2', 'EEF1B2']",0.9999957779687216,0,0,2
504,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9762015587989121,0.3455160440613027,0.008322168100815939,"['NDUFA7', 'NDUFB2']",0.9999957779687216,0,0,2
505,Disruption of postsynaptic signaling by CNV WP4875,0.9765408003395158,0.25930994256999285,0.006155693203332894,['YWHAG'],0.9999957779687216,0,0,1
506,Parkinson's disease pathway WP2371,0.9765408003395158,0.25930994256999285,0.006155693203332894,['CYCS'],0.9999957779687216,0,0,1
507,Target Of Rapamycin (TOR) Signaling WP1471,0.9765408003395158,0.25930994256999285,0.006155693203332894,['DDIT4L'],0.9999957779687216,0,0,1
508,PDGF Pathway WP2526,0.98332921689195,0.23702184391344477,0.003984646399883775,['SHC1'],0.9999957779687216,0,0,1
509,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9838781341815801,0.3188273651635721,0.005181976720451954,"['TNIP2', 'FN1']",0.9999957779687216,0,0,2
510,3q29 copy number variation syndrome WP4906,0.985383794882043,0.3127846454131425,0.004605464335703699,"['PIGM', 'SLC51A']",0.9999957779687216,0,0,2
511,Regulation of Microtubule Cytoskeleton WP2038,0.9881540365950198,0.21825291872898325,0.002600851479631336,['CAMK4'],0.9999957779687216,0,0,1
512,Energy Metabolism WP1541,0.9924892214241681,0.19739855741291493,0.001488212696396262,['CAMK4'],0.9999957779687216,0,0,1
513,Androgen receptor signaling pathway WP138,0.9931259060149824,0.326771728026032,0.002254015634175647,"['CDKN1A', 'LIMK2', 'FLNA']",0.9999957779687216,0,0,3
514,Wnt Signaling Pathway WP363,0.9932979437743935,0.19279119851750445,0.0012964467508749036,['NFATC2'],0.9999957779687216,0,0,1
515,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9952382319465065,0.18017104154311933,0.0008599818556956467,['CHEK2'],0.9999957779687216,0,0,1
516,Ciliopathies WP4803,0.9957023034871252,0.44627744627744625,0.001922098287029582,"['EVC2', 'DNAH11', 'SPAG1', 'IFT27', 'PKD1L1', 'CCDC65', 'CCDC151', 'GLI2']",0.9999957779687216,0,0,8
517,Fragile X Syndrome  WP4549,0.9988893409372859,0.2976213623695638,0.00033073956683965207,"['SHC1', 'BDNF', 'CAMK4', 'GAB1']",0.9999957779687216,0,0,4
518,DNA Repair Pathways Full Network WP4946,0.999632018423315,0.2314747005112976,8.519410114820397e-05,"['POLE4', 'POLD4', 'RPA3']",0.9999957779687216,0,0,3
519,Joubert Syndrome WP4656,0.9996521600456447,0.11987473599883475,4.170447636033015e-05,['FLNA'],0.9999957779687216,0,0,1
520,Genes related to primary cilium development (based on CRISPR) WP4536,0.9998500935082983,0.16849929627023222,2.5261031801704605e-05,"['EVC2', 'IFT27']",0.9999957779687216,0,0,2
521,Ciliary landscape WP4352,0.9999889803705986,0.24873373504497423,2.740968682084103e-06,"['WHRN', 'CDH23', 'USH1C', 'IFT27', 'STOM', 'MAPRE2']",0.9999957779687216,0,0,6
522,mRNA Processing WP411,0.9999957779687216,0.06638607785471135,2.8028468883647307e-07,['U2AF1'],0.9999957779687216,0,0,1
